Method and apparatus for atrial tachyarrhythmia detection

By implanting motion sensors in the ventricle, sensing atrial mechanical events and ventricular event signals, combined with irregular analysis of the ventricular cycle length, the problem of difficult to distinguish atrial rapid arrhythmia and ventricular rapid arrhythmia in the prior art is solved. Accurate detection and distinction of rapid atrial arrhythmia is achieved, and the accuracy and effectiveness of treatment are improved.

CN119075192APending Publication Date: 2024-12-06MEDTRONIC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411445051.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-11-12
Filing Date
2019-11-11
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing implantable pacemakers are difficult to accurately distinguish between atrial rapid arrhythmia and ventricular rapid arrhythmia, especially when atrial rapid arrhythmia is not effectively terminated.

Method used

Using an implantable medical device, the atrial mechanical event signal and ventricular event signal are sensed by implanting motion sensors in the ventricle, combined with irregular analysis of the ventricular cycle length, atrial rapid arrhythmia is determined, and the atrial is reduced through the scoring system. Vibration detection possibility.

Benefits of technology

Accurate detection and distinction of rapid atrial arrhythmia is achieved, the accuracy and effectiveness of treatment are improved, and unnecessary treatment measures are reduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119075192A_ABST
    Figure CN119075192A_ABST
Patent Text Reader

Abstract

The present disclosure relates to methods and devices for atrial tachyarrhythmia detection. An implantable medical device configured to determine a first atrial arrhythmia score from ventricular events sensed by sensing circuitry of the implantable medical device and a second atrial arrhythmia from intraventricular signals comprising atrial mechanical event signals accompanying ventricular systolic periods and generated by sensors of the implantable medical device and frequently scoring. An atrial arrhythmia is detected based on the first atrial arrhythmia score and the second atrial arrhythmia score.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of an invention patent application with an international application date of 2019 / 11 / 11, international application number PCT / US2019 / 060731, application number 201980074315.1 entering the Chinese national phase, and titled “Methods and devices for detecting atrial tachyarrhythmias”. Technical Field

[0002] The present disclosure relates to an implantable medical device and method for detecting atrial tachyarrhythmias using intraventricular sensor signals including atrial mechanical event signals. Background Art

[0003] Implantable cardiac pacemakers are typically placed in a subcutaneous pocket and coupled to one or more transvenous medical electrical leads that carry pacing and sensing electrodes positioned in the heart. A subcutaneously implanted cardiac pacemaker may be a single-chamber pacemaker that is coupled to one transvenous medical lead to position electrodes in one heart chamber, the atrium or ventricle, or a dual-chamber pacemaker that is coupled to two intracardiac leads to position electrodes in both the atrial and ventricular chambers. Multi-chamber pacemakers are also available that may be coupled to three leads, for example, for positioning electrodes for pacing and sensing in one atrial chamber and both the left and right ventricles.

[0004] Recently, intracardiac pacemakers have been introduced that are implantable within the ventricular chamber of a patient's heart for delivering ventricular pacing pulses. Such pacemakers can sense the R-wave signal accompanying intrinsic ventricular depolarization, and deliver ventricular pacing pulses in the absence of a sensed R-wave. While single-chamber ventricular sensing and pacing by intracardiac ventricular pacemakers can adequately address certain cardiac conditions, some patients may benefit from atrial and ventricular (dual-chamber) sensing for providing atrial-synchronized ventricular pacing and maintaining a more normal heart rhythm.

[0005] Some patients with pacemakers may experience tachyarrhythmias, such as ventricular tachycardia (VT) or ventricular fibrillation (VF), which may originate from the ventricular chambers. However, a fast ventricular rate may originate from the atrial chambers and be conducted from the atrial chambers to the ventricles of patients with intact atrioventricular rhythms. Atrial arrhythmias originating from the upper heart chambers and conducted to the ventricles are sometimes referred to as supraventricular tachyarrhythmias (SVT). Anti-tachycardia pacing therapy (ATP) and / or cardioversion shocks may be delivered to the ventricles to treat VT or VF, but may be ineffective in terminating SVT. Thus, distinguishing SVT from VT and VF enables correct diagnosis and treatment of heart rhythm conditions. Summary of the invention

[0006] The technology disclosed herein generally relates to an implantable medical device configured to detect atrial tachyarrhythmias. An implantable medical device operated according to the technology disclosed herein can be implanted in a ventricle of a patient's heart. The device has a sensor configured to generate an intraventricular signal containing a mechanical atrial contraction event signal. In some instances, the sensor is a motion sensor, such as an accelerometer, configured to generate an intraventricular motion signal. The medical device can be an intraventricular pacemaker, which is configured to sense an atrial mechanical event accompanying an atrial contraction period from a motion signal and sense a ventricular event from a cardiac electrical signal and / or a motion signal for determining a ventricular cycle length (VCL). The pacemaker can detect atrial tachyarrhythmias based on an analysis of VCL irregularity and evidence of atrial mechanical events determined from intraventricular signals. In some instances, detecting an atrial mechanical event from an intraventricular motion signal during irregular VCL can be used to determine an atrial event evidence score, which can be used to reduce the possibility of detecting atrial fibrillation by an implantable medical device.

[0007] In one example, the present disclosure provides an implantable medical device, the implantable medical device comprising: a sensor configured to generate an intraventricular signal including an atrial mechanical event signal accompanying an atrial mechanical contraction period; a sensing circuit configured to sense a ventricular event sensed by the sensing circuit; a memory configured to store atrial arrhythmia attack event data; and a control circuit coupled to the sensor, the sensing circuit and the memory. The control circuit can be configured to determine a first atrial arrhythmia score from the sensed ventricular event. The atrial arrhythmia score is associated with the presence of an atrial arrhythmia. The control circuit is further configured to determine a second atrial arrhythmia score from the intraventricular signal based on the atrial mechanical event signal, and detect an atrial arrhythmia based on the first atrial arrhythmia score and the second atrial arrhythmia score. The control circuit can generate an atrial arrhythmia detection notification in response to detecting the atrial arrhythmia. In some instances, the control circuit updates the atrial arrhythmia episode event data stored in the memory, the update including an indication of the atrial arrhythmia detection. The implantable medical device may include a telemetry circuit configured to transmit the updated atrial arrhythmia episode event data. The updated atrial arrhythmia episode event data may be transmitted to an external device to generate a display of the updated atrial arrhythmia episode event data. In some instances, the implantable medical device includes a pulse generator configured to adjust or withhold pacing therapy in response to the control circuit detecting the atrial arrhythmia.

[0008] In another example, the present disclosure provides a method, the method comprising determining a first atrial arrhythmia score from a ventricular event sensed by a sensing circuit of an implantable medical device. The first atrial arrhythmia score is associated with the presence of an atrial arrhythmia. The method further comprises determining a second atrial arrhythmia score from an intraventricular signal generated by a sensor of the implantable medical device. The intraventricular signal comprises an atrial mechanical event signal accompanying an atrial contraction period. The second atrial arrhythmia score is based on the atrial mechanical event signal. The method comprises detecting an atrial arrhythmia based on the first atrial arrhythmia score and the second atrial arrhythmia score, and updating atrial arrhythmia attack event data stored in a memory of the implantable medical device in response to detecting the atrial arrhythmia. The update comprises an indication of the detected atrial arrhythmia. The method may comprise transmitting the updated atrial arrhythmia attack event data. In some examples, the updated atrial arrhythmia attack event data is transmitted to an external device to generate a display of the atrial arrhythmia attack event data. In some examples, the method includes adjusting or withholding ventricular pacing therapy generated by a pulse generator of an implantable medical device in response to detecting the atrial arrhythmia.

[0009] In another example, the present disclosure provides a non-transitory computer-readable storage medium, the non-transitory computer-readable storage medium including a set of instructions, when executed by a control circuit of an implantable medical device, the instructions cause the device to determine a first atrial arrhythmia score from a ventricular event sensed by a sensing circuit of the implantable medical device and a second atrial arrhythmia score from an intraventricular signal generated by a sensor of the implantable medical device. The first atrial arrhythmia score is associated with the presence of an atrial arrhythmia. The intraventricular signal includes an atrial mechanical event signal accompanying an atrial systole. The second atrial arrhythmia score is based on the atrial mechanical event signal. The instructions further cause the implantable medical device to detect an atrial arrhythmia based on the first atrial arrhythmia score and the second atrial arrhythmia score, and in response to detecting the atrial arrhythmia, update atrial arrhythmia episode event data stored in a memory of the implantable medical device. The instructions may cause the device to transmit the atrial arrhythmia episode event data in response to the update, the update including an indication of the detected atrial arrhythmia. In some examples, the updated atrial arrhythmia episode event data is transmitted to an external device to generate a display of the atrial arrhythmia episode event data. The instructions may cause a pulse generator of the implantable medical device to adjust or withhold ventricular pacing therapy in response to detecting the atrial arrhythmia.

[0010] The details of one or more aspects of the disclosure are set forth in the drawings and description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] Figure 1 is a conceptual diagram illustrating an intracardiac pacing system that may be used to detect atrial tachyarrhythmias in accordance with the techniques disclosed herein.

[0012] Figure 2 yes Figure 1 A conceptual diagram of an intracardiac pacemaker is shown.

[0013] Figure 3 yes Figure 1 A schematic diagram of an example configuration of a pacemaker is shown.

[0014] Figure 4 can be included in Figure 1 Example of a motion signal generated by a motion sensor in a pacemaker during the cardiac cycle.

[0015] Figure 5 According to an example, Figure 1 Flowchart of a method performed by a pacemaker for detecting arrhythmias.

[0016] Figure 6 is a flow chart of a method for detecting tachyarrhythmia according to another example.

[0017] Figure 7 Depicted are examples of intraventricular motion sensor signals acquired during two different cardiac cycles.

[0018] Figure 8 is a flow chart of a method for determining an atrial arrhythmia evidence score based on a combination of atrial events sensed from a motion signal and ventricular cycle length.

[0019] Fig. 9 is a flow chart of a method for detecting atrial arrhythmias that may be performed according to another example.

[0020] Fig.10 is a flow chart of a method for detecting atrial arrhythmias using an intraventricular motion sensor signal and a VCL according to another example.

[0021] Fig.11 are graphs of example accelerometer signals, electrocardiogram (ECG) signals with event markers, and ventricular electrogram (EGM) signals during non-atrial tracking pacing mode with normal AV intact conduction.

[0022] Fig.12is a graph of an example accelerometer signal, ECG signal with event markers, and ventricular EGM signal during atrial fibrillation. DETAILED DESCRIPTION

[0023] In general, the present disclosure describes techniques for detecting atrial tachyarrhythmias by an implantable medical device. In various instances, the implantable medical device is a fully implantable intracardiac pacemaker in a ventricular chamber. The P wave that accompanies atrial depolarization is typically difficult to reliably sense from cardiac electrical signals received by an intracardiac ventricular pacemaker. P wave sensing may not be suitable for detecting and distinguishing atrial tachyarrhythmias from ventricular tachyarrhythmias by an intracardiac ventricular pacemaker. However, the detection and differentiation of atrial tachyarrhythmias and ventricular tachyarrhythmias is important information that clinicians are increasingly expecting to receive from implantable pacemakers, which have both atrial electrodes and ventricular electrodes at appropriate locations in the atrial heart chamber and the ventricular heart chamber, respectively, for sensing atrial electrical signals and ventricular electrical signals. Detection and differentiation of atrial arrhythmias from ventricular arrhythmias can also be used by implantable pacemakers to properly control therapy delivery.

[0024] Using the technology disclosed herein, a single-chamber intraventricular pacemaker is configured to detect atrial tachyarrhythmias based on a combination of analysis of ventricular events and analysis of atrial mechanical events sensed from intraventricular signals. As described below, atrial mechanical events accompanying atrial mechanical contraction periods are sensed from intraventricular signals generated by sensors contained in an implanted pacemaker within the ventricular cavity of the heart. For example, the motion signal generated by the accelerometer contains an atrial contraction event signal corresponding to atrial mechanical contraction and the active filling period of the ventricle, sometimes referred to as "atrial drive". The sensor signal obtained from the ventricular cavity is referred to herein as an "intraventricular signal". The intraventricular pacemaker can receive cardiac electrical signals for sensing R waves accompanying ventricular depolarization to determine evidence of atrial arrhythmias. For example, irregularity of the VCL is a positive indicator of atrial fibrillation (AF). As disclosed herein, an intraventricular pacemaker may be configured to use evidence of one or more atrial contraction mechanical events sensed from intraventricular signals to reduce the likelihood of detecting atrial fibrillation based on evidence of VCL irregularity.

[0025] Figure 1is a conceptual diagram showing an intracardiac pacing system 10 that can be used to sense cardiac electrical signals and motion signals induced by cardiac motion and flowing blood, and to provide pacing therapy to a patient's heart 8. The system 10 includes a ventricular intracardiac pacemaker 14 that can be capable of wireless communication with an external device 20. The pacemaker 14 can be a transcatheter intracardiac pacemaker that is adapted to be implanted entirely within a cardiac chamber for sensing cardiac signals and delivering ventricular pacing pulses, for example, entirely within the right ventricle (RV) of the heart 8 or entirely within the left ventricle (LV) of the heart. The pacemaker 14 is reduced in size compared to a subcutaneously implanted pacemaker and can be generally cylindrical in shape to enable transvenous implantation via a delivery catheter.

[0026] As shown, the pacemaker 14 is positioned in the RV along the endocardial wall, for example, near the RV apex, although other locations are possible. The technology disclosed herein is not limited to Figure 1 The pacemaker locations shown in the example of are not limited to the locations of the pacemakers in the embodiment of FIG. 1 , and other locations within the heart 8 are possible. For example, a ventricular intracardiac pacemaker 14 can be positioned in the LV and configured to detect cardiac motion signals and determine ventricular cycle length for detecting atrial tachyarrhythmias using the techniques disclosed herein. The pacemaker 14 can be positioned in the RV or LV to provide right ventricular pacing or left ventricular pacing, respectively, sensing cardiac electrical signals and sensing cardiac motion signals via motion sensors within the ventricular chambers.

[0027] The pacemaker 14 is capable of generating electrical stimulation pulses, e.g., pacing pulses, delivered to the heart 8 by one or more electrodes on the external housing of the pacemaker. For example, in the illustrated positioning, the pacemaker 14 is configured to deliver RV pacing pulses using housing-based electrodes and sense RV cardiac electrical signals for use in generating RV electrogram (EGM) signals. The cardiac electrical signals may be sensed using housing-based electrodes that are also used to deliver pacing pulses to the RV.

[0028] The pacemaker 14 can be configured to control ventricular pacing in a manner that promotes synchronization between atrial activation and ventricular activation, for example, by maintaining a target atrioventricular (AV) interval between atrial pacing pulses and ventricular pacing pulses delivered by the pacemaker 14. In other words, the pacemaker 14 controls the delivery of ventricular pacing pulses to maintain a desired AV interval between atrial contraction corresponding to atrial systole and a ventricular pacing pulse that is delivered to cause ventricular depolarization followed by ventricular contraction corresponding to ventricular systole. Sometimes, the pacemaker 14 can be configured to control the delivery of ventricular pacing pulses to the RV to maintain a desired minimum ventricular rate that is asynchronous with atrial events, for example, in VVI or VVIR pacing modes. The minimum ventricular rate can be a programmed lower rate, for example, 40 to 60 pulses per minute or a temporarily lower rate set based on patient activity as an indication of metabolic demand. The pacemaker 14 may use the motion signal from the motion sensor to determine a patient activity metric for use in controlling the ventricular pacing rate to meet the metabolic demands of the patient, as indicated by the patient activity metric.

[0029] Atrial contraction events that produce active ventricular filling periods are detected by the pacemaker 14 from a motion sensor, such as an accelerometer, enclosed by the housing of the pacemaker 14. The motion signal generated by the accelerometer implanted in the ventricular chamber contains motion signals caused by ventricular and atrial events. For example, the acceleration of blood flowing through the tricuspid valve 16 between the RA and RV into the RV caused by atrial contraction or "atrial drive" can be detected by the pacemaker 14 from the signal generated by the accelerometer contained in the pacemaker 14. Other cardiac signals that can be detected by the pacemaker 14 from the intraventricular motion signal, such as cardiac motion signals caused by ventricular contraction and relaxation, are described below, for example, in conjunction with Figure 4 Give a description.

[0030] The atrial P wave accompanying atrial depolarization is a relatively low amplitude signal (e.g., compared to the near-field R wave) in the near-field ventricular cardiac electrical signal received by the pacemaker 14, and therefore may be difficult to reliably detect from the cardiac electrical signal acquired by the pacemaker 14 implanted in the ventricular chamber. Detection of atrial rhythm by the pacemaker 14 for tachyarrhythmia monitoring and / or atrial synchronous ventricular pacing may be unreliable when based solely on the cardiac electrical signal received by the pacemaker 14. According to the technology disclosed herein, the pacemaker 14 includes a motion sensor, such as an accelerometer, and is configured to detect atrial events corresponding to atrial mechanical activation or atrial contraction from a signal generated by the motion sensor. Ventricular pacing pulses can be synchronized with atrial events detected from the motion sensor signal by setting a programmable AV pacing interval, which controls the timing of the ventricular pacing pulse relative to the detected atrial contraction event. As described below, atrial event detection from motion signals can be used to detect atrial tachyarrhythmias that are additionally based on analysis of the VCL, which is determined as the time interval between consecutive ventricular events (eg, sensed R-waves).

[0031] The pacemaker 14 may be capable of bidirectional wireless communication with an external device 20 to program cardiac electrical signal sensing and pacing control parameters and mechanical event (motion signal) sensing parameters, which can be used to detect ventricular mechanical events and atrial contraction events from the motion sensor signals. Aspects of the external device 20 may generally correspond to the external programming / monitoring unit disclosed in U.S. Pat. No. 5,507,782 (Kieval et al.). The external device 20 is generally referred to as a "programmer" because it is typically used by a physician, technician, nurse, clinician or other qualified user to program operating parameters in the pacemaker 14. The external device 20 may be located in a clinic, hospital or other medical facility. The external device 20 may alternatively be embodied as a home monitor or handheld device that can be used in a medical facility, a patient's home or another location. The operating parameters including sensing and therapy delivery control parameters can be programmed into the pacemaker 14 using the external device 20.

[0032] The external device 20 is configured for bidirectional communication with implanted telemetry circuitry contained in the pacemaker 14. The external device 20 establishes a wireless communication link 24 with the pacemaker 14. The external device 20 may be configured to establish the communication link 24 using a Wi-Fi, Medical Implant Communications Service (MICS), or other radio frequency (RF) link of a communication bandwidth. In some instances, the external device 20 may include a programming head placed proximate to the pacemaker 14 to establish and maintain the communication link 24, and in other instances, the external device 20 and the pacemaker 14 may be configured to communicate using distance telemetry and circuitry that does not require the use of a programming head and does not require user intervention to maintain the communication link. An example RF telemetry communication system that may be implemented in the system 10 is generally disclosed in U.S. Pat. No. 5,683,432 (Goedeke et al.). The external device 20 may display data and information related to the function of the pacemaker to the user for the user to view parameters of pacemaker operation and programming as well as EGM signals transmitted from the pacemaker 14 during an interrogation session, motion sensor signals acquired by the pacemaker 14, or other physiological data acquired by the pacemaker 14 and retrieved from the pacemaker. The data transmitted from the pacemaker 14 to the external device 20 may include motion sensor signals, cardiac electrical signals and / or marker channels that indicate the timing and spacing of events associated with tachyarrhythmia detection sensed from onset events of the motion sensor signals and / or cardiac electrical signals.

[0033] It is contemplated that the external device 20 may be wired or wirelessly connected to a communication network via telemetry circuitry including a transceiver and antenna or via hardwired communication lines for transmitting data to a centralized database or computer to allow remote management of the patient. A remote patient management system including a centralized patient database may be configured to utilize the presently disclosed techniques to enable a clinician to view the EGM, motion sensor signals, and marker channel data and authorize programming of sensing and therapy control parameters in the pacemaker 14, for example, after viewing a visual representation of the EGM, motion sensor signals, and marker channel data.

[0034] Figure 2 yes Figure 1 1. A conceptual diagram of an intracardiac pacemaker 14 is shown. The pacemaker 14 includes electrodes 162 and 164 spaced apart along a housing 150 of the pacemaker 14 for sensing cardiac electrical signals and delivering pacing pulses. Electrode 164 is shown as a tip electrode extending from a distal end 102 of the pacemaker 14, and electrode 162 is shown as a ring electrode along a mid-portion of the housing 150 (e.g., adjacent the proximal end 104). The distal end 102 is referred to as "distal" because it is expected to be the leading end when the pacemaker 14 is advanced through a delivery tool (e.g., a catheter) and placed against a targeted pacing site.

[0035] Electrodes 162 and 164 form an anode and cathode pair for bipolar cardiac pacing and sensing. In alternative embodiments, the pacemaker 14 may include two or more ring electrodes, two tip electrodes, and / or other types of electrodes exposed along the pacemaker housing 150 for delivering electrical stimulation to the heart 8 and sensing cardiac electrical signals. Electrodes 162 and 164 may be, but are not limited to, titanium, platinum, iridium, or alloys thereof, and may include low polarization coatings such as titanium nitride, iridium oxide, ruthenium oxide, platinum black, and the like. Electrodes 162 and 164 may be positioned at other locations along the pacemaker 14 than those shown.

[0036] The housing 150 is formed of a biocompatible material, such as stainless steel or a titanium alloy. In some instances, the housing 150 may include an insulating coating. Examples of insulating coatings include polyparaxylene, urethane, PEEK, or polyimide, among others. The entirety of the housing 150 may be insulated, but only the electrodes 162 and 164 are not insulated. The electrode 164 may serve as a cathode electrode and may be coupled to an internal circuit system enclosed by the housing 150, such as a pacing pulse generator and a cardiac electrical signal sensing circuit system, via an electrical feedthrough across the housing 150. The electrode 162 may be formed as a conductive portion of the housing 150 that defines a ring electrode that is electrically isolated from other portions of the housing 150, such as Figure 2 In other examples, instead of providing a localized annular electrode such as anode electrode 162, the entire periphery of housing 150 can serve as an electrode electrically insulated from tip electrode 164. Electrode 162 formed along the conductive portion of housing 150 serves as a return anode during pacing and sensing.

[0037] Housing 150 includes a control electronics subassembly 152 that houses electronics for sensing cardiac signals, generating pacing pulses, and controlling therapy delivery and other functions of pacemaker 14, as described below in conjunction with Figure 3 In some examples, the motion sensor can be implemented as an accelerometer enclosed within housing 150. In some examples, the accelerometer provides a signal to a processor contained in control electronics subassembly 152 for signal processing and analysis for detecting atrial contraction events for tachyarrhythmia detection and for timing ventricular pacing pulses.

[0038] The accelerometer may be a three-dimensional accelerometer having one "longitudinal" axis parallel or aligned with the longitudinal axis 108 of the pacemaker 14 and two orthogonal axes extending radially relative to the longitudinal axis 108. However, the practice of the technology disclosed herein is not limited to a particular orientation of the accelerometer within or along the housing 150. In other examples, a one-dimensional accelerometer may be used to obtain an intracardiac motion signal from which atrial contraction events are detected. In still other examples, a two-dimensional accelerometer or other multi-dimensional accelerometer may be used. Each axis of a one-dimensional or multi-dimensional accelerometer may be defined by a piezoelectric element, a microelectromechanical system (MEMS) device, or other sensor element capable of generating an electrical signal in response to a change in acceleration imparted on the sensor element, for example, by converting the acceleration into a force or displacement, which is converted into an electrical signal. In a multi-dimensional accelerometer, the sensor elements may be arranged orthogonally, with each sensor element axis being orthogonal relative to the other sensor element axes. However, an orthogonal arrangement of the elements of a multi-axis accelerometer is not necessarily required.

[0039] Each sensor element can generate an acceleration signal corresponding to a vector aligned with an axis of the sensor element. One, two, or all three vector signals generated by the three-dimensional accelerometer can be selected for use in detecting atrial contraction events, for use in detecting and distinguishing tachyarrhythmias, and for controlling atrial-synchronous ventricular pacing delivered by pacemaker 14.

[0040] Housing 150 further includes a battery subassembly 160 that provides power to control electronics subassembly 152. Battery subassembly 160 may include features of the batteries disclosed in commonly assigned US Pat. Nos. 8,433,409 (Johnson et al.) and 8,541,131 (Lund et al.).

[0041] The pacemaker 14 may include a set of fixation tines 166 to secure the pacemaker 14 to patient tissue, for example, by actively engaging the ventricular endocardium and / or interacting with ventricular trabeculae. The fixation tines 166 are configured to anchor the pacemaker 14 to position the electrodes 164 operatively proximate to targeted tissue for delivery of therapeutic electrical stimulation pulses. Various types of active and / or passive fixation members may be employed for anchoring or stabilizing the pacemaker 14 in an implanted position. The pacemaker 14 may include a set of fixation tines as disclosed in commonly assigned U.S. Pat. No. 9,775,872 (Grubac et al.).

[0042] The pacemaker 14 may optionally include a delivery tool interface 158. The delivery tool interface 158 may be positioned at the proximal end 104 of the pacemaker 14 and configured to connect to a delivery device (e.g., a catheter) used to position the pacemaker 14 at an implantation site during an implantation procedure, for example, within a heart chamber.

[0043] Figure 3 yes Figure 1 Schematic diagram of an example configuration of a pacemaker 14 shown. The pacemaker 14 includes a pulse generator 202, a cardiac electrical signal sensing circuit 204, a control circuit 206, a memory 210, a telemetry circuit 208, a sensor 212, and a power supply 214. The sensor 212 is configured to generate an intraventricular signal including an atrial mechanical event signal accompanying an atrial mechanical contraction period. The illustrative examples described in conjunction with the accompanying drawings primarily refer to intraventricular signals generated by a motion sensor. Therefore, the sensor 212 may also be referred to as a "motion sensor 212" herein. However, the technology disclosed herein may be implemented in conjunction with other sensors capable of generating an intraventricular signal including an atrial mechanical event signal. Examples of sensors for sensing mechanical atrial contraction events for determining an atrial arrhythmia score that may be included in the sensor 212 include motion sensors, such as piezoelectric sensors or MEMS devices, impedance sensors capable of injecting an impedance drive current (or voltage) signal and sensing the resulting intraventricular voltage (or current) signal, or pressure sensors for sensing intraventricular pressure signals as examples.

[0044] When the sensor 212 comprises an impedance sensor, an atrial contraction event signal accompanying a mechanical atrial contraction or "atrial drive" may be detected from the intraventricular impedance signal using techniques for detecting the A wave portion of the impedance signal, as generally disclosed in U.S. Patent No. 8,639,328 (Hettrick et al.). When the sensor 212 comprises a pressure sensor, an atrial contraction event signal accompanying a mechanical atrial contraction may be detected from the intraventricular pressure signal using techniques generally disclosed in U.S. Publication No. 2011 / 0160787 (Greenhut et al.). Atrial contraction events sensed from the intraventricular sensor signal may be used to determine an atrial event evidence score for use in atrial tachyarrhythmia detection as described below.

[0045] In some examples, the sensor 212 may include a multi-axis accelerometer, such as a two-dimensional or three-dimensional accelerometer, where each axis provides a signal that can be analyzed individually or in combination for detecting cardiac mechanical events. The motion sensor 212 generates an electrical signal related to the motion or vibration of the sensor 212 (and the pacemaker 14), for example, when subjected to flowing blood, cardiac motion, and patient physiological activity. The motion sensor 212 may include one or more filters, amplifiers, rectifiers, analog-to-digital converters (ADCs), and / or other components for generating motion signals that are transmitted to the control circuit 206. For example, each vector signal corresponding to each individual axis of the multi-axis accelerometer may be filtered by a high pass filter (e.g., a 10 Hz high pass filter), digitized by the ADC, and rectified for use by the atrial event detector circuit 240 to detect atrial contraction events. In other examples, if it is necessary to detect atrial signals with higher or lower frequency content, the high pass filter may have a higher or lower cutoff frequency, such as 5 Hz. In some examples, high pass filtering is performed without low pass filtering. In other examples, each accelerometer axis signal is filtered by a low pass filter (eg, a 30 Hz low pass filter) with or without high pass filtering.

[0046] One example of an accelerometer used in an implantable medical device that may be included in the motion sensor 212 is generally disclosed in U.S. Pat. No. 5,885,471 (Ruben et al.). Implantable medical device arrangements that include piezoelectric accelerometers for detecting patient motion are disclosed, for example, in U.S. Pat. No. 4,485,813 (Anderson et al.) and U.S. Pat. No. 5,052,388 (Sivula et al.). Examples of three-dimensional accelerometers that may be implemented in a pacemaker 14 using the presently disclosed technology and used to detect cardiac mechanical events are generally described in U.S. Pat. No. 5,593,431 (Sheldon) and U.S. Pat. No. 6,044,297 (Sheldon). Other accelerometer designs may be used to generate electrical signals related to motion imparted on the pacemaker 14 due to ventricular and atrial events.

[0047] Figure 3 The various circuits represented may be combined on one or more integrated circuit boards including application specific integrated circuits (ASICs), electronic circuits, processors (shared, dedicated, or grouped) and memories that execute one or more software or firmware programs, combinational logic circuits, state machines, or other suitable components that provide the described functionality.

[0048] The sensing circuit 204 is configured to receive cardiac electrical signals through electrodes 162 and 164 by a pre-filter and amplifier circuit 220. The pre-filter and amplifier circuit may include a high pass filter for removing DC offset, for example, a high pass filter of 2.5 to 5 Hz, or a wideband filter with a passband of 2.5 Hz to 100 Hz to remove DC offset and high frequency noise. The pre-filter and amplifier circuit 220 may further include an amplifier to amplify the "raw" cardiac electrical signals passed to an analog-to-digital converter (ADC) 226. The ADC 226 may pass a multi-bit digital electrogram (EGM) signal to the control circuit 206 for use by the atrial event detector circuit 240 and / or the processor 244 to identify ventricular electrical events (e.g., R waves or T waves) and / or atrial electrical events, for example, P waves. The identification of cardiac electrical events may be used to detect atrial contraction events from the motion sensor signal and to determine cardiac event intervals for detecting and distinguishing ventricular tachyarrhythmias from SVT. The digital signal from the ADC 226 may be passed to a rectifier and amplifier circuit 222 , which may include a rectifier, a bandpass filter, and an amplifier, for passing the cardiac signal to an R-wave detector 224 .

[0049] The R-wave detector 224 may include a sense amplifier or other detection circuitry that compares the incoming rectified cardiac electrical signal to an R-wave sensing threshold, which may be an automatically adjusted threshold. When the incoming signal crosses the R-wave detection threshold, the R-wave detector 224 generates an R-wave sensed event signal (R-sense) that is transmitted to the control circuit 206. In other examples, the R-wave detector 224 may receive the digital output of the ADC 226 for detecting the R-wave by a comparator, morphological signal analysis of the digital EGM signal, or other R-wave detection techniques. The processor 244 may provide sensing control signals to the sensing circuit 204, such as an R-wave sensing threshold, sensitivity, and various blanking and refractory intervals applied to the cardiac electrical signal to control R-wave sensing. The R-wave sensed event signal transmitted from the R-wave detector 224 to the control circuit 206 may be used to schedule ventricular pacing pulses by the pacing timing circuit 242 and to determine the VCL for atrial tachyarrhythmia detection, as described below. The R-wave sensed event signal received from R-wave detector 224 may also be used by atrial event detector circuit 240 to detect atrial contraction events from the signal received by motion sensor 212. For example, the R-wave sensed event signal may be used to set one or more timing windows to facilitate sensing atrial events from the motion signal and to determine how many atrial events are sensed during a single VCL.

[0050] Control circuit 206 includes atrial event detector circuit 240, pacing timing circuit 242, and processor 244. Atrial event detector circuit 240 is configured to detect atrial mechanical events and, in particular, atrial contraction events from signals received by motion sensor 212. In some examples, one or more ventricular mechanical events may be detected from the motion sensor signal in a given cardiac cycle to facilitate positive detection of an atrial contraction event from the motion sensor signal during the ventricular cycle.

[0051] The control circuit 206 can receive R-wave sensed event signals and / or digital cardiac electrical signals from the sensing circuit 204 for detecting and confirming cardiac events and controlling ventricular pacing. When the pacemaker 14 is operating in a non-atrial tracking ventricular pacing mode, the R-wave sensed event signal can be transmitted to the pacing timing circuit 242 to suppress the scheduled ventricular pacing pulse or schedule a ventricular pacing pulse. The pacing timing circuit 242 can determine the time interval between consecutive received R-wave sensed event signals, referred to herein as the RR interval or RRI, for use by the processor 244 in rapid arrhythmia detection. As described below, the difference between consecutive ventricular cycle lengths (VCL) can be determined to determine a measure of VCL irregularity as evidence of AF. The VCL can be the RRI, the time interval between a ventricular pacing pulse and an R-wave sensed event signal, or the time interval between two consecutive ventricular pacing pulses.

[0052] The R-wave sensed event signal may be communicated to an atrial event detector circuit 240 for use in setting a time window used by the control circuit 206 in detecting an atrial contraction event from the motion sensor signal. The atrial event detector circuit 240 receives the motion signal from the motion sensor 212 and may initiate an atrial blanking period in response to a ventricular electrical event (e.g., an R-wave sensed event signal from the sensing circuit 204 or a pacing pulse delivered by the pulse generator 202). The blanking period may correspond to a time period following a ventricular electrical event during which a ventricular mechanical event, such as corresponding to ventricular contraction and isovolumetric relaxation, is expected to occur. Motion signal peaks occurring during the atrial blanking period are not sensed as atrial events to avoid mis-sensing ventricular motion signal events as atrial contraction events.

[0053] The atrial event detector circuit 240 determines whether the motion sensor signal meets the atrial mechanical event detection criteria outside of the atrial blanking period. In some instances, the motion sensor signal during the blanking period can be monitored by the atrial event detector circuit 240 and / or the processor 244 for detecting ventricular mechanical events, which can be used to confirm or verify atrial contraction event detection or detect a ventricular event interval. In this way, a ventricular mechanical event detection window can be set during the atrial blanking period, and the ventricular mechanical event detection window can be set according to a predetermined time interval after the identification of a ventricular electrical event. The control circuit 206 can be configured to detect one or more ventricular mechanical events during the corresponding ventricular event detection window during the atrial blanking period. The timing and detection of ventricular mechanical events can be used to update the atrial blanking period and / or can be used to confirm the detection of an atrial event that occurs after an expected ventricular mechanical event.

[0054] Atrial event detector circuit 240 can set time windows corresponding to passive ventricular filling period and active ventricular filling period based on the timing of previous ventricular electrical events (R-wave sensed event signals or ventricular pacing pulses). Motion sensor signals that cross the atrial event sensing threshold during either of these windows can be detected as atrial contraction events. As described below, two different atrial event sensing thresholds can be established for application during the passive filling period window and after the passive filling period window (during the active filling period window).

[0055] Atrial event detector circuit 240 communicates an atrial event detection signal to processor 244 and / or pacing timing circuit 242 in response to detecting an atrial event. Processor 244 may include one or more clocks for generating clock signals used by pacing timing circuit 242 to time out an AV pacing interval that begins upon receipt of the atrial event detection signal from atrial event detector circuit 240. Pacing timing circuit 242 may include one or more escape interval timers or counters for timeout of an AV pacing interval (which may be a programmable interval stored in memory 210) and that may be retrieved by processor 244 for use in setting the AV pacing interval used by pacing timing circuit 242.

[0056] The pacing timing circuit 242 may additionally include a lower pacing rate interval timer for controlling the minimum ventricular pacing rate. For example, if an atrial contraction event that triggers a ventricular pacing pulse at a programmed AV pacing interval is not detected from the motion sensor signal, a ventricular pacing pulse may be delivered by the pulse generator 202 after the lower pacing rate interval expires to prevent ventricular asystole and maintain the minimum ventricular rate. Sometimes, the control circuit 206 may control the pulse generator 202 in a non-atrial tracking ventricular pacing mode (also referred to as "asynchronous ventricular pacing"). The non-atrial tracking ventricular pacing mode may be represented as a VDI pacing mode in which ventricular pacing pulses are delivered in the absence of a sensed R wave and are suppressed in response to an R wave sensed event signal from the sensing circuit 204. Dual chamber sensing may be performed during a non-atrial tracking ventricular pacing mode by sensing ventricular electrical events by sensing circuit 204 and sensing atrial events by atrial event detector circuit 240 receiving a motion signal from motion sensor 212 .

[0057] Processor 244 can receive atrial sensed event signals from atrial event detector circuit 240 and R-wave sensed event signals from sensing circuit 204 for tachyarrhythmia detection. Processor 244 can determine the difference between consecutive VCLs to determine VCL irregularity. In some instances, two consecutively determined VCL differences define an ordered coordinate pair (x, y) of points plotted in a two-dimensional Lorentz plot. The clustering and distribution of Lorentz plot points determined from a series of VCL differences can be analyzed to determine a measure or score of VCL variability as evidence of atrial tachyarrhythmia (e.g., AF). The measure or score may be described herein as an atrial arrhythmia score. Typically, an atrial arrhythmia score provides an indication of an atrial arrhythmia and is associated with the presence of an atrial arrhythmia and may be based on VCL irregularity.

[0058] In some examples, an AF evidence score (also referred to herein as an atrial arrhythmia score) may be determined from the VCL difference, as generally disclosed in, for example, U.S. Pat. No. 7,627,368 (Houben et al.), U.S. Pat. No. 7,031,765 (Ritscher et al.), U.S. Pat. No. 7,537,569 (Sarkar et al.), and U.S. Pat. No. 7,623,911 (Sarkar et al.). In response to receiving a detected atrial mechanical event signal from the atrial event detector circuit 240, the processor 244 may determine a second atrial arrhythmia score, also referred to herein as an atrial event score, which may be evidence against atrial arrhythmia because the unique atrial mechanical event signal accompanying atrial systole is expected to occur at a very low frequency or be absent during AF. The second atrial arrhythmia score or atrial event score may be used to adjust the AF evidence score to reduce the likelihood of detecting AF during periods of irregular VCL. In some instances, the absence of an atrial mechanical event signal is evidence in support of AF detection and can be used to increase the likelihood of detecting AF, for example, by lowering the criteria or requirements for detecting AF based on the AF evidence score. Thus, in some instances, the second atrial arrhythmia score can be negatively correlated with the presence of an atrial arrhythmia.

[0059] The pulse generator 202 generates electrical pacing pulses that are delivered to the RV of the patient's heart through the cathode electrode 164 and the return anode electrode 162. In addition to providing control signals to the pacing timing circuit 242 and the pulse generator 202 to control the timing of the ventricular pacing pulses, the processor 244 can retrieve programmable pacing control parameters such as pacing pulse amplitude and pacing pulse width that are passed to the pulse generator 202 for controlling the delivery of pacing pulses. The pulse generator 202 can include a charging circuit 230, a switching circuit 232, and an output circuit 234.

[0060] The charging circuit 230 may include a holding capacitor that may be charged to a pacing pulse amplitude at a multiple of the battery voltage signal of the power supply 214 under the control of a voltage regulator. The pacing pulse amplitude may be set based on a control signal from the control circuit 206. The switch circuit 232 may control when the holding capacitor of the charging circuit 230 is coupled to the output circuit 234 for delivery of a pacing pulse. For example, the switch circuit 232 may include a switch that is activated by a timing signal received from the pacing timing circuit 242 at the expiration of an AV pacing interval (or a VV lower rate pacing interval) and remains closed at a programmed pacing pulse width to enable the holding capacitor of the charging circuit 230 to discharge. The holding capacitor previously charged to the pacing pulse voltage amplitude is discharged through the output capacitor of the output circuit 234 at the electrodes 162 and 164 for the programmed pacing pulse duration. Examples of pacing circuit systems are generally disclosed in U.S. Pat. No. 5,507,782 (Kieval et al.) and U.S. Pat. No. 8,532,785 (Crutchfield et al.) and may be implemented in the pacemaker 14 for charging a pacing capacitor to a predetermined pacing pulse amplitude and delivering pacing pulses under the control of the control circuit 206.

[0061] The control circuit 206 can be configured to control the pulse generator 202 to deliver ventricular pacing pulses according to an atrial tracking ventricular pacing mode (sometimes referred to as a VDD mode) or according to a non-atrial tracking ventricular pacing mode (e.g., VDI(R) or VVI(R)). The control circuit 206 can control pacing mode switching between the atrial tracking pacing mode and the non-atrial tracking pacing mode. For example, the pacemaker 14 can switch from the atrial tracking ventricular pacing mode to the non-atrial tracking ventricular pacing mode in response to detecting high patient activity or loss of atrial event sensing. Methods for controlling pacing mode switching in an intracardiac ventricular pacemaker with a motion sensor are generally disclosed in U.S. Patent No. 9,399,140 (Cho et al.) and U.S. Patent Application No. 15 / 366,933 (Demmer et al.).

[0062] In some instances, the pacemaker 14 can be configured to deliver anti-tachycardia pacing (ATP) in response to detecting VT. VT can be detected in response to a predetermined number of RRIs being within the VT interval region and not meeting AF detection criteria. As described herein, during a rapid or irregular ventricular rate, when at least one atrial event is detected from the motion sensor signal, the AF detection criteria may not be met. If the VT criteria are met due to an atrial event being sensed from the motion signal and the AF detection criteria are not met, the control circuit 206 can control the pulse generator 202 to deliver one or more ATP therapy sequences.

[0063] The memory 210 may contain computer readable instructions that, when executed by the control circuit 206, cause the control circuit 206 to perform various functions of the pacemaker 14 as provided in the present disclosure. The computer readable instructions may be encoded within the memory 210. The memory 210 may contain any non-transitory computer readable storage medium, including any volatile, non-volatile, magnetic, optical, or electrical medium, such as a random access memory (RAM), a read-only memory (ROM), a non-volatile RAM (NVRAM), an electrically erasable programmable ROM (EEPROM), flash memory, or other digital media. The memory 210 may store timing intervals and other data used by the control circuit 206 to control the delivery of pacing pulses by the pulse generator 202, for example, by detecting an atrial event from a motion sensor signal by the atrial event detector circuit 240 and setting an escape interval timer included in the pacing timing circuit 242.

[0064] The memory 210 may be configured to store tachyarrhythmia episode data for transmission to the external device 20. In some examples, in response to detecting AF, the control circuit 206 may store segments of the ventricular EGM signal and / or motion sensor signal and / or store data related to atrial tachyarrhythmia episode detection, such as updating an atrial tachyarrhythmia or AF burden measure, storing the number and duration of detected atrial tachyarrhythmia episodes, etc. The control circuit 206 may store similar data associated with ventricular tachyarrhythmia episode detection, such as a VT episode record of the EGM signal and / or motion signal, the number of detected VT episodes and the corresponding VT episode durations, and any delivered ATP therapy and treatment results.

[0065] In some examples, the control circuit 206 can be configured to generate an alarm or notification in response to detecting an atrial tachyarrhythmia or when (e.g., x minutes in the last 24 hours) the atrial tachyarrhythmia burden reaches a threshold level. The alarm can be transmitted to the external device 20 via the telemetry circuit 208 to notify the patient and / or clinician of the detected atrial tachyarrhythmia. The VT alarm can be generated in response to detecting one or more VT episode events.

[0066] A power source 214, which may be included in the battery subassembly 160, provides power to each of the other circuits and components of the pacemaker 14 when needed. The power source 214 may include one or more energy storage devices, such as one or more rechargeable or non-rechargeable batteries. For clarity, the connections between the power source 214 and the other pacemaker circuits and components are not shown. Figure 3 However, it should be Figure 3For example, the power supply 214 can provide power to the charging and switching circuitry included in the pulse generator 202; the amplifier, ADC 226 and other components of the sensing circuit 204; the telemetry circuit 208; the memory 210 and the motion sensor 212 as needed.

[0067] Telemetry circuit 208 includes a transceiver 209 and an antenna 211 for transmitting and receiving data, for example, via a radio frequency (RF) communication link. Telemetry circuit 208 may be capable of communicating with external device 20 ( Figure 1 ) for two-way communication. Programmable control parameters for controlling and executing the following various pacemaker functions can be received by the telemetry circuit 208 and stored in the memory 210 for access by the control circuit 206: such as atrial event detection, ventricular pacing, rapid arrhythmia detection, and one or more associated responses, such as generating notifications or alarms or controlling therapies. The intraventricular signals sensed by the sensor 212, such as motion sensor signals and cardiac electrical signals, and / or data derived therefrom can be transmitted by the telemetry circuit 208 to the external device 20. For example, the control circuit 206 can generate an atrial arrhythmia attack event notification and / or update the atrial arrhythmia attack event data stored in the memory 201, and control the telemetry circuit 206 to transmit the notification and / or the updated atrial arrhythmia attack event data to the external device 20 to generate a display of the atrial arrhythmia attack event data. Atrial arrhythmia episode data may include the following: a record of intraventricular signals including indications of sensed atrial contraction events, cardiac electrical signals including indications of sensed R waves, atrial arrhythmia episode duration, atrial arrhythmia burden, a number of atrial arrhythmia episodes detected, and / or other atrial arrhythmia episode data. Display of the data provides useful diagnostic information to a clinician in selecting or managing therapy for a patient.

[0068] The functionality possessed by the pacemaker 14 herein may be embodied as one or more processors, controllers, hardware, firmware, software, or any combination thereof. The description of the different features of a specific circuit system is intended to highlight the different functional aspects and does not necessarily imply that such functionality must be implemented by separate hardware, firmware, or software components or by any particular circuit architecture. Instead, the functionality associated with one or more circuits described herein may be performed by separate hardware, firmware, or software components, or may be integrated within common hardware, firmware, or software components. For example, atrial contraction event detection from motion sensor signals, ventricular pacing control operations, and rapid arrhythmia detection performed by the pacemaker 14 may be implemented in a control circuit 206 that executes instructions stored in a memory 210 and relies on inputs from a sensing circuit 204 and a motion sensor 212. Given the disclosure herein, it is within the capabilities of a person skilled in the art to provide software, hardware, and / or firmware to accomplish the described functionality in the context of any modern pacemaker.

[0069] Figure 4 is an example of a motion sensor signal 250 across the cardiac cycle that can be generated by the motion sensor 212 during normal sinus rhythm or atrial synchronized ventricular pacing. The vertical dashed lines 252 and 262 represent the timing of two consecutive ventricular events (intrinsic ventricular depolarization or ventricular pacing), marking the beginning and end of the ventricular cycle 251, respectively. The motion signal includes an A1 event 254, an A2 event 256, an A3 event 258, and an A4 event 260. The A1 event 254 is an acceleration signal that occurs during ventricular contraction (in this example, when the motion sensor 212 is implemented as an accelerometer) and marks the mechanical contraction of the ventricles. The A1 event is also referred to as a "ventricular contraction event" in this article. The A2 event 256 is an acceleration signal that can occur during the closure of the aortic and pulmonary valves, and marks the approximate offset or end of the mechanical contraction period of the ventricles. The A2 event can also mark the beginning of ventricular diastole, and is usually an indication of the isovolumetric relaxation period of the ventricles that occurs with the closure of the aortic and pulmonary valves. The A1 and A2 events may mark the beginning and end of a contraction time interval, respectively.

[0070] The A3 event 258 is an acceleration signal that occurs during passive ventricular filling and marks ventricular mechanical relaxation. The A3 event is also referred to herein as the "A3 signal" and the "ventricular passive filling event". Since the A2 event occurs at the end of the ventricular systole, it is an indicator of the beginning of the ventricular diastole. The A3 event occurs during the ventricular diastole. Thus, the A2 and A3 events can be collectively referred to as ventricular mechanical diastolic events because they are both indicators of the ventricular diastole.

[0071] The A4 event 260 is an acceleration signal that occurs during atrial contraction and active ventricular filling and marks a period of atrial mechanical contraction. The A4 event 260 is also referred to herein as an "A4 signal" detected from the motion sensor signal 250, as an "atrial contraction event," or simply as an "atrial event." The atrial event detector circuit 240 detects the A4 event 260 and can pass the atrial sensed event signal to the processor 244 for atrial tachyarrhythmia detection. In some instances, the A4 event signal is used by the pacing timing circuit 242 to trigger a ventricular pacing pulse by starting an AV pacing interval in response to detecting the A4 event 260. The control circuit 206 can be configured to detect one or more of the A1, A2, and A3 events from the motion sensor signal 250 during at least some ventricular cardiac cycles for positively detecting the A4 event 260 and setting an atrial event detection control parameter. A1, A2, and / or A3 events can be detected and characterized to avoid false detection of A4 events and to facilitate reliable A4 event detection, for example, to facilitate high confidence in A4 event detection during atrial tachyarrhythmia detection and proper timing of atrial synchronized ventricular pacing pulses. In some instances, an A1 or A2 event can be used to determine VCL in lieu of or in addition to an R wave sensed from a cardiac electrical signal.

[0072] Figure 5 300 is a flowchart of a method for detecting arrhythmias that can be performed by a pacemaker 14 according to an example. At box 302, the control circuit 206 identifies a ventricular event. The ventricular event can include a sensed R wave, a ventricular pacing pulse, or an A1 or A2 event sensed from a motion signal. The control circuit 206 determines a first atrial tachyarrhythmia score based on the identified ventricular event at box 304. In some examples, the first atrial tachyarrhythmia score can be based on a VCL determined between consecutive pairs of identified ventricular events. As described below, the first atrial tachyarrhythmia score can be based on a pattern of consecutive VCL differences. The first atrial tachyarrhythmia score determined based on the VCL at box 304 can be positively correlated with the occurrence of atrial tachyarrhythmia, for example, irregular VCL occurs during AF. In this case, a relatively higher first atrial tachyarrhythmia score corresponds to an increased probability of the presence of an atrial tachyarrhythmia.

[0073] At box 306, the control circuit 206 determines a second atrial tachyarrhythmia score from the motion signal received by the motion sensor 212. In some instances, the second atrial tachyarrhythmia score can be negatively correlated with the occurrence of atrial arrhythmias. For example, the second atrial tachyarrhythmia score can be increased in response to detecting an A4 signal from the motion signal as evidence of a ventricular contraction beat, which is evidence that the opposing rhythm is AF. For example, if the A4 signal amplitude is always 0.2g units (1g is the acceleration of gravity) and then drops by more than 50% to less than 0.1g units during AF, A4 events will no longer be detected. If one or more A4 events are detected, the rhythm is unlikely to be AF.

[0074] In other examples, the second atrial tachyarrhythmia score based on the motion signal can also be positively correlated with the occurrence of an atrial tachyarrhythmia, in which case the second atrial tachyarrhythmia score can be increased when an atrial tachyarrhythmia is likely to be present. For example, in response to detecting a shortening of the systolic time interval from the motion signal, the second atrial arrhythmia score can be increased. As described below, the systolic time interval can be determined from the motion signal as the A1-A2 interval extending between the A1 event 254 and the A2 event 256 (e.g., Figure 4 ). Detection of a shortened systolic time interval can be positive evidence for detecting an atrial tachyarrhythmia such as AF. In this case, when a shortened A1-A2 interval is detected, the second atrial tachyarrhythmia score can increase and be positively correlated with an atrial tachyarrhythmia.

[0075] In another example, if multiple A4 events are sensed during a single VCL, the presence of multiple A4 events can indicate atrial flutter. A second atrial tachyarrhythmia score can be increased in response to detecting multiple A4 events within a single VCL, and the second atrial tachyarrhythmia score can serve as positive evidence for detecting an atrial tachyarrhythmia (e.g., atrial flutter).

[0076] At box 308, the control circuit 206 can adjust the first atrial arrhythmia score based on the second atrial arrhythmia score. For example, when the first score is positively correlated with atrial tachyarrhythmia and the second score is negatively correlated with atrial tachyarrhythmia, the first atrial arrhythmia score can be reduced by the second atrial arrhythmia score. As described below, the first atrial tachyarrhythmia score can be an AF evidence score determined from the VCL and will increase during a time period of irregularity in the VCL, which may occur during AF. The second atrial tachyarrhythmia score can be an atrial event evidence score determined by counting A4 events sensed from the motion signal during the VCL. As the atrial event evidence score increases, indicating that the occurrence of atrial contraction events was not detected during AF, the probability that the rhythm is AF decreases. Therefore, at box 306, the second atrial arrhythmia score can be subtracted from the first atrial arrhythmia score.

[0077] In instances where the second atrial arrhythmia score is positively correlated with the presence of an atrial tachyarrhythmia, the second atrial tachyarrhythmia score may be added to the first atrial tachyarrhythmia score at block 308. For example, if the second atrial tachyarrhythmia score is increased in response to detecting a shortened time interval between an A1 event and an A2 event or in response to detecting multiple A4 events within a single VCL, then at block 308, the first atrial tachyarrhythmia score may be increased by increasing the second atrial tachyarrhythmia score.

[0078] At box 310, the cardiac rhythm can be classified as an atrial tachyarrhythmia or a non-atrial tachyarrhythmia based on the adjusted first atrial tachyarrhythmia score. Various examples are described below for classifying the cardiac rhythm based on the adjusted first atrial tachyarrhythmia score, and subsequently detecting atrial tachyarrhythmias and responding to atrial tachyarrhythmia detections. For example, the first atrial tachyarrhythmia score adjusted by the second atrial tachyarrhythmia score can be determined for one or more time segments of the cardiac electrical signal and / or motion signal. The adjusted first atrial tachyarrhythmia score can be compared to a threshold value for classifying the cardiac rhythm during the time segment. As further described below, the control circuit 206 can adjust the threshold value compared to the first atrial tachyarrhythmia score based on the analysis of the motion signal to increase or decrease the likelihood of detecting an atrial tachyarrhythmia based on the first atrial tachyarrhythmia score. It may be desirable to classify one or more time segments as atrial tachyarrhythmia in order to perform atrial tachyarrhythmia detection and provide a response to atrial tachyarrhythmia detection.

[0079] Figure 6350 is a flow chart of a method for detecting a tachyarrhythmia according to one example. The control circuit 206 may perform the method of the flow chart 350 on an ongoing basis for monitoring atrial tachyarrhythmias. In other examples, the control circuit 206 may perform the method of the flow chart 350 periodically. Figure 6 When the pacemaker 14 is operating in a non-atrial tracking (asynchronous) ventricular pacing mode (e.g., VDI pacing mode), the combination of Figure 6 A disclosed atrial tachyarrhythmia detection method and other flow charts and figures presented herein. In some instances, atrial tachyarrhythmia detection can be performed in both an atrial tracking (synchronous) ventricular pacing mode and a non-atrial tracking ventricular pacing mode. When operating in an atrial synchronous pacing mode or an atrial asynchronous pacing mode, a pacing interlock can be implemented that prevents atrial tachyarrhythmia detection when a threshold percentage of ventricular events are paced with the ventricular cycle. In this way, during VDD pacing mode, for example, when A4 events are regularly sensed resulting in frequent synchronous ventricular pacing greater than the pacing interlock threshold percentage, atrial tachyarrhythmia detection is prevented.

[0080] At block 352, control circuit 206 identifies a ventricular event for use in determining a ventricular cycle length (VCL) at block 354. The ventricular event may be a ventricular pacing pulse or a sensed R-wave. For example, control circuit 206 may receive an R-wave sensed event signal from sensing circuit 204. At block 354, a VCL between the received R-wave sensed event signal and a most recent previous ventricular electrical event (e.g., a most recent previous ventricular pacing pulse or an R-wave sensed event signal) is determined as the VCL.

[0081] VCL may be determined between two intrinsic sensed R-waves, between an intrinsic sensed R-wave and a ventricular pacing pulse, and in some cases between two ventricular pacing pulses. Figure 6 The atrial tachyarrhythmia detection techniques described in the methods and in conjunction with other flowcharts and diagrams presented herein generally refer to the determination of VCL based on ventricular electrical events (e.g., sensed intrinsic R waves and ventricular pacing pulses). However, it should be understood that in other examples, VCL can be determined based on mechanical events detected from the motion signal received by the motion sensor 212. For example, VCL can be determined as an A1-A1 interval or an A2-A2 interval (see Figure 4 A1 event 254 and A2 event 256).

[0082] At block 356, the control circuit 206 may determine an AF evidence score based on VCLs acquired within a predetermined time interval or based on the most recent predetermined number of VCLs. Figure 8 A method for determining an AF evidence score is briefly described and other example techniques for determining an AF score are disclosed in U.S. Pat. No. 7,627,368 (Houben et al.), U.S. Pat. No. 7,031,765 (Ritscher et al.), U.S. Pat. No. 7,537,569 (Sarkar et al.), and U.S. Pat. No. 7,623,911 (Sarkar et al.), incorporated above. An AF evidence score can be determined based on the distribution of differences between consecutive VCLs. In general, a more dispersed distribution of VCL differences is evidence of VCL irregularity and supports the detection of AF.

[0083] At box 358, the control circuit 206 can determine whether an atrial event is detected from the motion signal during the VCL used to determine the AF evidence score. Specifically, the control circuit 206 can determine how accurately the VCL contains an A4 event sensed during a single corresponding VCL. The control circuit 206 updates the atrial event evidence score based on the atrial events sensed from the motion signal at box 360. The atrial event evidence score can be a measure indicating the number of atrial events detected with a high degree of certainty during a predetermined time interval or a predetermined number of VCLs. The presence of a clear or well-defined atrial contraction event signal in the motion signal, particularly a single sensed A4 event per VCL, is evidence of a counter AF rhythm because atrial fibrillation does not produce active atrial filling or atrial drive that produces an A4 event signal in the intraventricular motion sensing signal.

[0084] As the atrial event evidence score increases, the likelihood of the presence of a true AF rhythm decreases. Any irregularity of the VCL that may result in a high AF evidence score may be more likely to be due to ventricular tachyarrhythmias, atrial or ventricular ectopic operation, or other abnormal rhythms other than AF. Thus, the atrial event evidence score is used to adjust the AF evidence score at box 362. In some instances, the atrial event evidence score is subtracted from the AF evidence score so that the higher the atrial event evidence score is due to a correspondingly higher number of atrial events sensed during the VCL, the more the AF evidence score can be reduced. In other instances, a single sensed atrial event or a predetermined number of sensed atrial events sensed during the VCL used to determine the AF evidence score may cause the control circuit 206 to adjust the AF evidence score by a predetermined decrement. In some instances, the AF evidence score is reduced by the atrial event evidence score only when the AF evidence score is greater than a predetermined threshold and / or the atrial event evidence score is greater than a predetermined threshold. Other methods may be used to adjust the AF evidence score based on the atrial event evidence score so as to generally reduce the likelihood of detecting AF when at least one atrial contraction event is detected from the motion signal during the VCL used to determine the AF evidence score.

[0085] At box 364, the AF evidence score is compared to the AF detection threshold. If the AF evidence score is less than the AF evidence detection threshold after being adjusted as needed by the atrial event evidence score, the process returns to box 352 to continue determining the VCL for determining the next AF evidence score. If the AF evidence score is greater than the AF evidence detection threshold, at box 366, the control circuit 206 may classify the interval for which the VCL is determined as an AF interval. If a threshold number of AF intervals are detected (box 368), AF is detected at box 370. The threshold number of AF intervals required to detect AF may be one or more. When two or more AF intervals need to be classified as AF intervals in order to detect AF, the AF intervals may be consecutive or may not need to be consecutive. In some instances, techniques for detecting AF based on time intervals classified as AF (or non-AF) as generally disclosed in U.S. Publication No. 2018 / 0028086 (Cao et al.) can be used in combination with techniques for adjusting the AF evidence score based on analysis of motion signals as disclosed herein.

[0086] In other instances, the control circuit 206 may use the AF evidence score and the atrial event evidence score in one or more logical operations for detecting AF, rather than adjusting the AF evidence score by the atrial event evidence score. For example, in one logical operation, the AF evidence score is required to be equal to or greater than the AF detection threshold, and the atrial event evidence score is required to be less than the atrial event threshold in order to detect AF. If one of these conditions is not met, AF will not be detected. Multiple logical operations may be performed using different hierarchical combinations of AF detection thresholds and atrial event thresholds. For example, if the AF evidence score is less than a first AF detection threshold, the atrial event evidence score may be compared to a second, lower atrial event threshold. If the atrial event evidence score is less than the second, lower atrial event threshold, and the AF evidence score is greater than the second, lower AF detection threshold, AF may still be detected.

[0087] The pacemaker 14 may be configured to provide an AF detection response at box 372. The AF detection response may include generating an AF detection notification and / or storing data related to the AF episode event, such as a time and date stamp of the AF detection, the duration of the AF episode event, the ventricular rate during the AF episode event, or other AF episode related data. The AF detection response may include storing a time segment of the cardiac electrical signal and / or the intraventricular motion signal acquired during the detected AF episode event. The stored signal data and / or other AF episode event data may be transmitted to an external device, such as the external device 20, for generating a display of atrial arrhythmia episode event data for viewing by a clinician. In some examples, the control circuit 206 may be configured to sum the duration of all AF episode events detected within a predetermined time period (e.g., within a 24-hour, a week, a month, or other time period). The accumulated duration of the AF episode event may be stored in the memory 210 as an AF burden, which is updated in response to each AF detection and may be transmitted to the external device 20.

[0088] In addition to or in lieu of updating and storing data related to AF episode events, the control circuit 206 may provide an AF response by switching pacing modes at box 372. The pacemaker 14 may operate in an atrial tracking ventricular pacing mode (e.g., VDD). In response to detecting AF, at box 372, the control circuit 206 may switch to a non-atrial tracking ventricular pacing mode, e.g., VDI or VVI. In some instances, the control circuit 206 may switch back to the atrial tracking pacing mode when AF is no longer detected.

[0089] In some instances, if the pacemaker 14 is configured to detect VT or VF and deliver ATP, the AF detection response provided at box 372 may include withholding ATP. In some patients who develop SVT, atrial depolarization during AF may be erratically conducted to the ventricles. It is expected that ATP delivered to the ventricles during AF may not effectively terminate the tachyarrhythmia. Therefore, in some instances, the control circuit 206 may be configured to withhold VT detection and / or ATP therapy delivery at box 372 in response to detecting AF.

[0090] Figure 7 is an example of motion sensor signals 400 and 410 acquired during two different cardiac cycles. At time 0.0 seconds of both cardiac cycles, a ventricular pacing pulse is delivered. The top sensor signal 400 is received during one cardiac cycle, and the bottom sensor signal 410 is received during a different cardiac cycle. The two signals 400 and 410 are compared in time at time 0.0 seconds of the ventricular pacing pulse delivery. Although Figure 7Motion signals 400 and 410 and motion signal 250 are shown as raw accelerometer signals, however, it should be recognized that control circuit 80 can receive digitized filtered, amplified and rectified signals from motion sensor 212 for processing and analysis for sensing atrial events used in tachyarrhythmia detection.

[0091] It is observed that the A1 events 402 and 412 of the corresponding motion sensor signals 400 and 410 occurring during ventricular systole are well aligned in time after the ventricular pacing pulse at time 0.0 seconds. Similarly, the A2 events 404 and 414 (marking the end of the isovolumetric ventricular diastole and ventricular systole and the beginning of the ventricular diastole) and the A3 events 406 and 416 (occurring during passive ventricular filling during ventricular diastole) are well aligned in time. Since the A1 event, A2 event, and A3 event are ventricular events occurring during ventricular systole, isovolumetric ventricular diastole, and passive ventricular filling, respectively, these events are expected to occur at relatively consistent intervals after a ventricular electrical event (in this example, a ventricular pacing pulse). The temporal relationship of the A1 event, A2 event, and A3 event after the ventricular pacing pulse can be different from the temporal relationship after the sensed intrinsic R wave. However, during stable pacing or intrinsic ventricular rhythm, the relative timing of the A1, A2, and A3 events to each other and to the immediately preceding ventricular electrical event is expected to be relatively consistent from beat to beat. However, in the presence of AF, the time interval 452 between the A1 and A2 events can be shortened. Shortening of the A1-A2 interval can occur during AF due to changes in the filling of the heart chambers, resulting in earlier closure of the aortic and pulmonary valves and a shortening of the systolic time interval. In some instances, the A1-A2 interval 452 can be determined by the control circuit 206 for use as positive evidence of AF in detecting atrial arrhythmias. Detection of a shortened A1-A2 interval can be used by the control circuit 206 to increase the likelihood of detecting AF in the presence of VCL irregularities.

[0092] The A4 events 408 and 418 of the first motion sensor signal 400 and the second motion sensor signal 410, respectively, are not aligned in time. The A4 event occurs during atrial systole, and thus the time interval between the immediately preceding ventricular electrical event (a sensed R-wave or ventricular pacing pulse) and the preceding A1 event to the A3 event followed by the A4 event may vary between cardiac cycles.

[0093] The timing of the A1 to A3 events relative to each other and the immediately preceding ventricular electrical event can be used to determine an atrial blanking period 436 and increase confidence in reliably detecting the A4 events 408 and 418. No atrial contraction events are detected during the atrial blanking period 436 extending from the ventricular electrical event (at time 0.0) to the beginning of the estimated ventricular diastole, such that the atrial blanking period 436 contains both the A1 event and the A2 event. An A3 sensing window 424 can be set with a start time 420 and an end time 425 corresponding to the end of the post-ventricular atrial blanking period 436. The end time 425 can be established based on the timing of the A3 event or the expected end time of the passive ventricular filling period following the ventricular electrical event.

[0094] A4 events 408 and 418 may be detected based on a multi-level A4 sensing threshold 444. As shown by the lower motion sensor signal 410, the A4 event 418 may occur earlier after the A3 window 424 due to changes in the atrial rate. In some cases, the A4 event 418 may occur within the A3 window 424 when the atrial rate increases. When this occurs, the A3 event 416 and the A4 event 418 may fuse as passive and active ventricular filling occur together. The fused A3 / A4 event may have a high amplitude, even greater than the amplitude of the A3 event 416 or the A4 event 418 when they occur separately. As such, in some instances, a first higher A4 sensing threshold amplitude 446 may be established for detecting an early A4 signal that fuses with the A3 signal during the A3 window 424. A second lower A4 sensing threshold amplitude 448 may be established for detecting a relatively late A4 signal after the end time 425 of the A3 window 424. The A3 window end time 425 may also be considered the start time of the A4 sensing window 450, although an A4 signal may be sensed during the A3 window when crossing the higher sensing threshold amplitude 446. After the A3 window start time 420 (or after the expiration of the atrial blanking period 436), the earliest crossing of the A4 detection threshold 444 by the motion sensor signal may be sensed as an atrial contraction event.

[0095] Ventricular A1 events and A2 events may be sensed by the control circuit 206 during the atrial blanking period 436 for monitoring the shortening of the A1-A2 interval. The A1 window 420 may be set based on an expected A1 time interval 430 between a ventricular electrical event and the A1 event 402 or 412. The A2 window 422 may be set based on an expected time interval 432 from a ventricular electrical event until an A2 event 404 or 414. The timing of the A1 window 420 and the A2 window 422 may be adapted to the changing ventricular rate. An A1 sensing threshold 440 may be applied to the motion sensor signal during the A1 window 420, and an A2 sensing threshold 442 may be applied to the motion signal during the A2 window 422. The time interval between the A1 sensing threshold crossing and the A2 sensing threshold crossing may be determined by the control circuit 206 as the A1-A2 interval 452. In other examples, in addition to or instead of two respective threshold crossings during set time windows 420 or 422, morphological waveforms or features of the A1 and A2 signals may be used to detect A1 and A2 events and subsequently determine A1-A2 interval shortening.

[0096] Figure 8 500 is a flow chart of a method for determining an AF evidence score based on a combination of atrial events sensed from a motion signal and a VCL. The analysis of the VCL and the sensed atrial events can be determined within a predetermined time interval (e.g., one minute, two minutes, or other time interval that can be less than or greater than one minute). In one instance, the control circuit 206 sets a timer to two minutes at box 502. At box 504, a ventricular event is identified. The ventricular event can be an electrical event, such as a sensed intrinsic R wave or a delivered ventricular pacing pulse. In other instances, the ventricular event can be identified as a ventricular mechanical event (e.g., an A1 event) sensed from the motion signal generated by the motion sensor 212.

[0097] At box 506, the control circuit 206 determines whether a predetermined number of ventricular events (sensed R-waves, delivered ventricular pacing pulses, or a combination thereof) that meet the VCL criteria have been identified. For example, four ventricular events may be required to determine two consecutive VCL differences. A VCL is determined between two consecutively identified ventricular events (e.g., "V1" and "V2"). A second VCL that is consecutively subsequent to the first VCL is determined between the second ventricular event "V2" and the third ventricular event "V3". A VCL difference ΔVCL (e.g., VCL1-VCL2=ΔVCL1) may be determined between the first VCL and the second VCL. Therefore, three consecutively identified ventricular events V1, V2, and V3 are required to determine a VCL difference ΔVCL1.

[0098] In some instances, two VCL differences are determined to generate an ordered pair (ΔVCL1, ΔVCL2) that defines a point in a two-dimensional Lorentz plot area. The distribution of ordered pairs of VCL differences can be used to determine an AF evidence score. For example, the process of determining an AF evidence score can include filling the histogram bins of the two-dimensional Lorentz plot area with counts of ordered pairs (ΔVCL1, ΔVCL2) that fall within the range of each two-dimensional histogram bin, for example, as generally disclosed in the patents incorporated above. In order to determine two consecutive VCL differences to generate a data point defined by an ordered pair (ΔVCL1, ΔVCL2), four ventricular events need to be identified at box 506. The first three ventricular events V1, V2, and V3 define two consecutive VCLs and ΔVCL1. Another ventricular event "V4" defines a third consecutive VCL together with the previous ventricular event V3. The difference between the second VCL and the third VCL is determined as a second VCL difference ΔVCL2 for defining the ordered pair (ΔVCL1, ΔVCL2). Thus, the control circuit 206 continues to identify ventricular events at block 504 until four ventricular events are identified (at block 506) for determining two consecutive VCL differences at block 508.

[0099] In some instances, additional criteria are applied to the identified ventricular events and the VCL at box 506 prior to determining the VCL difference at box 508. For example, a maximum number of pacing pulses may be allowed, e.g., one ventricular pacing pulse out of four identified ventricular events. Additionally or alternatively, at box 506, each of the three VCLs defined by the four identified ventricular events may be required to be greater than a predetermined VCL threshold. According to one example, the control circuit 206 determines whether each of the VCLs is greater than 220 milliseconds. The interval threshold may be an SVT limit defined to reduce the likelihood of AF detection based on a VCL shorter than the SVT limit, which may be evidence of true rapid VT or VF.

[0100] At box 508, a VCL difference is determined from the N ventricular events that meet the VCL criteria. If the timer has not expired, the VCL difference will continue to be determined to generate an ordered pair of two consecutive VCL differences for populating the two-dimensional Lorentz plot histogram. In other examples, the VCL can be accumulated and analyzed according to other VCL or RRI-based AF detection criteria that do not necessarily collect VCL differences in ordered pairs to populate the Lorentz plot histogram. The technology disclosed herein for utilizing A4 events sensed from motion signals for detecting atrial beats as evidence against AF detection can be used in combination with multiple AF detection criteria.

[0101] The control circuit 206 may simultaneously acquire atrial event sensing data during a predetermined time period while the VCL data is being acquired. The control circuit 206 may determine whether an A4 signal is sensed during the predetermined time period. During the predetermined time period, the sensed A4 signal increases with one A4 event per VCL, the less likely AF is present. Thus, the increased evidence of one sensed atrial event per VCL is used to reduce the probability of AF being detected.

[0102] At box 510, the control circuit 206 can apply criteria to count A4 sensed events. In order to reduce the possibility of A4 over-detection, A4 event sensing for tachyarrhythmia detection can be performed only during the A4 window (e.g., the time interval between the previous A3 window end time and the next ventricular event). During a short VCL, A3 events can merge with A4 events, making it difficult to confidently distinguish A4 events, or A1 events can occur earlier and may be mis-sensed as A4 events during the A4 window. Therefore, criteria can be applied to the A4 window and / or VCL at box 510 to facilitate reliable A4 event sensing for determining atrial event evidence scores.

[0103] For example, Figure 7 The A4 window 450 shown in the A3 window end time 425 and the next ventricular event (identified at box 504) may need to be greater than a threshold time interval in order to count the A4 events sensed during the A4 window to reduce the probability of detecting AF. The A4 window may be required to be at least 400 milliseconds as an example. If the A4 window is less than the threshold duration, the A4 window may be ignored when determining the atrial event evidence score. In other examples, at box 510, the VCL may be required to be greater than a predetermined threshold so that the A4 event sensing used in the cumulative atrial event evidence against the detection of AF rhythm is performed during the corresponding A4 window. Instead of or in addition to the A4 window, a standard may be applied to the VCL at box 510. For example, the VCL ending with the ventricular event identified at box 504 may be required to be greater than a threshold VCL interval, for example, at least 700ms or greater. In other examples, the standard applied at box 510 may include a requirement for a minimum VCL difference between two consecutive VCLs so that A4 event sensing is used for AF detection. For example, the VCL may be required to be greater than a threshold interval, e.g., 700 to 800 ms, and the VCL difference from the previous VCL may be required to be greater than a difference threshold, e.g., 100 ms, in order for an A4 event to be counted to reduce the probability of detecting AF. The criteria applied at block 510 may be optional, and the control circuit 206 may increment the A4 count at block 514 in response to each A4 sensed event signal received from the atrial event detector 240 indicating a single A4 sense threshold crossing during the VCL.

[0104] If the A4 interval criteria are not met at block 510 or an A4 event is not sensed during the A4 window at block 512, the control circuit 206 awaits the next identified ventricular event at block 504. In response to sensing an A4 event that meets the criteria required at block 510 during the A4 window (the "yes" branch of block 512), the control circuit 206 may increase the value of the A4 counter at block 514. In other examples, the value of the A4 counter may be increased in response to the motion signal crossing the A4 threshold 444 during the A3 window 424 or during the A4 window 450 in the current ventricular cycle.

[0105] The control circuit 206 may compare the value of the A4 counter to the A4 evidence threshold at box 516. If the A4 count value has not yet reached the A4 evidence threshold (the "No" branch of box 516), the process returns to box 504 to identify the next ventricular event, as long as the predetermined time interval has not expired (the "No" branch of box 520). If the A4 evidence threshold is reached, then at box 518, the control circuit 206 may increase the atrial event evidence score. According to one example, in response to the A4 count reaching a value of four, the atrial event evidence score is increased by one. In other examples, the atrial event evidence score may be increased by one each time the A4 count reaches a predetermined value that may be less than or greater than four. In still other examples, the atrial event evidence score may be set equal to the A4 count so that the A4 count is used directly as the atrial event evidence score for adjusting the AF evidence score.

[0106] In some examples, at block 518, additional analysis may be performed on the A4 sensed event before increasing the atrial event evidence score. For example, an ensemble average may be performed on a predetermined number of sensed A4 event signals, where each signal is detected as one A4 signal per VCL. The control circuit 206 may determine one or more signal features from the ensemble averaged A4 signal and compare the signal features to criteria for confirming that the averaged signal represents a true A4 signal. If the A4 signal criteria are met, then at block 518, the control circuit 206 increases the atrial event evidence score.

[0107] After increasing the atrial event evidence score (block 518), if the timer has not expired ("No" branch of block 520), the control circuit 206 returns to block 504 to identify the next ventricular event and continue counting sensed A4 events and updating the atrial event evidence score at block 518 as needed. When the timer expires at block 520, the control circuit 206 can determine the percentage of ventricular events identified during the expired time period that were ventricular pacing pulses. After the VCL criteria are met at block 506, the percentage of ventricular pacing pulses can be determined from all identified ventricular events or only from the ventricular events used to determine the VCL.

[0108] If the percentage of ventricular events that are ventricular pacing pulses at box 522 is greater than the pacing limit threshold, the control circuit 206 may refuse to classify the currently expired time segment. VCL data acquired during relatively frequent ventricular pacing may be considered unreliable for detecting AF based on the VCL. If the pacing mode is an atrial tracking ventricular pacing mode, the high pacing frequency determined at box 522 may indicate a high incidence of A4 event sensing, which is a contraindication for detecting AF.

[0109] Thus, if the percentage of pacing pulses is greater than a threshold, e.g., greater than 30%, the control circuit 206 may refuse to determine an AF evidence score for the currently expiring time segment. In some instances, the currently expiring time segment may be ignored for purposes of detecting AF. In some instances, a predetermined number of time segments may be required to be classified as AF based on the AF evidence score in order to detect AF. In this case, the currently expiring time segment may not be classified based on the new AF evidence score, but may be given the same classification as the previous time segment maintained for the currently expiring time segment at box 524. For example, if the previous time segment was classified as AF, the currently expiring time segment may also be classified as AF. If the previous time segment was classified as non-AF, the currently expiring time segment may also be classified as non-AF.

[0110] When the percentage of pacing pulses at box 522 is less than the threshold, the control circuit 206 determines an AF evidence score at box 526 based on the VCL difference determined at box 508 and adjusted by the atrial event evidence score determined at box 518. The AF evidence score can be determined based on the distribution of ordered pairs of VCL differences in a two-dimensional Lorentz plot histogram. A large number of occupied histogram bars indicates high VCL irregularity and is evidence of AF. A high frequency of occupied histogram bars around the origin of the two-dimensional Lorentz plot coordinate system indicates very low VCL irregularity, which can be evidence of normal sinus rhythm or highly organized atrial tachycardia and does not indicate AF. In one instance, an AF evidence score based on VCL can be determined by subtracting the number of ordered pairs of VCL differences in histogram bars that fall within a defined area around the origin from the total number of occupied histogram bars outside the area around the origin. In some instances, evidence of regular premature atrial contractions (PACs) can be determined from a Lorenz plot histogram based on clustering of ordered pairs of VCL differences that are characteristic patterns of PACs. Frequent PACs can occur at regular coupling intervals and present a regular VCL pattern associated with, for example, bigeminy (short-short-long RRI) or trigeminy (short-short-long RRI). Thus, an AF evidence score before adjustment by an atrial event evidence score can be determined by subtracting the counts of ordered pairs within the origin region and subtracting the number of counts within a predetermined segment of the Lorenz plot histogram region corresponding to the PAC pattern of VCL. Various techniques that may be performed by the control circuit 206 for determining an AF evidence score based on the VCL or other VCL irregularity metrics are generally described in the above-incorporated U.S. Patent Nos. 7,031,765 (Ritscher et al.); 7,623,911 (Sarkar et al.); 7,537,569 (Sarkar et al.); and 7,627,368 (Sarkar et al.).

[0111] The AF evidence score determined based on the VCL difference can be adjusted based on the sensed incidence of atrial events. The control circuit 206 can subtract the atrial event evidence score determined at box 518 from the AF evidence score based on the VCL to obtain an adjusted AF evidence score at box 526. The adjusted AF evidence score is compared to the AF threshold for use at box 530 to classify the currently expiring time segment as, for example, AF or non-AF. The AF score threshold can be selected and optimized based on historical clinical data or historical individual patient data for a selected patient population, and the optimal AF score threshold setting can vary between patients. In an illustrative example, the possible range of AF scores can be 0 to 100. The AF score threshold can be set between 25 and 75. If the AF score reaches or crosses the AF score threshold, the time segment in which the VCL was collected and therefore the time segment in which the cardiac signal occurred is classified as an AF time segment. For example, as combined with Figure 6 As described, one or more AF time segments may be required to detect an AF rhythm.

[0112] Fig. 9 600 is a flowchart of a method for detecting AF that can be performed according to another example. At box 602, the control circuit 206 determines an AF evidence score based on the VCL difference, for example, using any of the techniques described above or in the incorporated references. At box 604, the control circuit 206 determines atrial event evidence. Atrial event evidence can be determined by counting the number of sensed A4 signals within a time period in which the VCL is determined for determining the AF evidence score, wherein the sensed A4 signals appear in the form of one sensed A4 signal per VCL. The atrial event evidence score can be determined based on the sensed A4 signals, for example, by increasing the atrial event evidence score by one after every four (or other predetermined number) A4 sensed event signals.

[0113] The control circuit 206 may determine at box 606 whether the AF threshold adjustment criteria are met. The control circuit 206 may compare the number of atrial events sensed within the time segment in which the VCL is acquired (one atrial event per VCL) to a threshold number at box 606. The number of sensed A4 signals or an atrial event evidence score based on the number of sensed A4 signals may be compared to the threshold. For example, if no more than one A4 event is sensed during a two-minute time segment, the AF threshold may be adjusted (e.g., lowered) at box 608 to increase the likelihood that the rhythm will be classified as AF and ultimately detected during the predetermined time segment. In other instances, another maximum predetermined number of sensed A4 events as low as zero A4 events may be defined as a criterion for adjusting the AF threshold in a manner that increases the likelihood of detecting AF. Few or no sensed A4 events during the VCL used to determine the AF evidence score is positive evidence of AF.

[0114] When determining whether the criteria for adjusting the AF detection threshold are met, the percentage of pacing during the time period for determining the AF evidence score may also be considered. For example, if 20% to 40% of the ventricular events identified for determining the VCL difference are paced pulses, and less than the maximum threshold number of A4 events are sensed, the AF detection threshold may be reduced at box 608. The presence of a higher percentage of paced ventricular cycles (e.g., greater than 40%) will reduce the AF evidence score because the irregularity of the VCL during frequent ventricular pacing will be reduced. To account for this reduced VCL irregularity, when few (or no) A4 events are sensed during relatively frequent pacing, the AF detection threshold may be lowered to still allow AF to be detected during pacing. Thus, the criteria defined at box 606 may define one or more ranges of pacing percentages and the corresponding maximum threshold number of sensed A4 events as criteria for adjusting the AF threshold by a corresponding predetermined amount.

[0115] During atrial tachycardia or atrial flutter, atrial beats may occur more than once during the A4 window. In some instances, multiple peaks or A4 threshold amplitude crossings during the A4 window may be evidence of an atrial tachyarrhythmia that is not AF. Thus, the atrial event evidence determination at box 604 may include determining the number of peaks during the A4 window or determining the number of A4 sensing threshold crossings during the A4 window. When multiple peaks or multiple A4 sensing threshold crossings occur within a single A4 window during one or more VCLs, the criteria for lowering the AF threshold are not met at box 606. When multiple A4 sensing threshold crossings or motion signal peaks occur within a single A4 window, the AF threshold may remain the same or even increase to reduce the likelihood of detecting AF.

[0116] At block 610, the control circuit 206 may adjust the VCL-based AF evidence score by subtracting the atrial event evidence score, as described above in conjunction with Figure 8 The adjusted AF evidence score is compared to the AF detection threshold at box 612, which may be the adjusted AF detection threshold if the criteria are met at box 606. In some examples, the AF detection threshold may be adjusted based on the absence of a sensed A4 signal with or without adjusting the AF evidence score based on evidence of atrial events.

[0117] If the AF evidence score is greater than the AF threshold at box 612, then at box 614, the heart rhythm during the time period in which the AF evidence score was determined is classified as AF. Figure 6 AF detection and AF detection response are performed as described. If the adjusted AF evidence score is not greater than the AF threshold, then at block 616, the time segment is not classified as AF. The process may return to block 602 to determine the AF evidence score for the next time segment.

[0118] In some examples, when the control circuit 206 determines that multiple A4 sensing threshold crossings occur within a single VCL for one or more VCLs when determining evidence of an atrial event at block 604, the control circuit 206 may detect the atrial tachyarrhythmia as atrial flutter rather than AF at block 614. Additional analysis may be performed at block 604 to determine whether the morphology of the multiple A4 sensing threshold crossing waveforms is similar and therefore represents a series of atrial flutter events. If the morphology is variable, the classification at block 614 may be AF. More generally, multiple A4 sensing threshold crossings within a single VCL may be evidence of an atrial tachyarrhythmia, and the classification made at block 614 may be an atrial tachyarrhythmia without distinguishing between atrial flutter and AF.

[0119] like Fig. 9 As shown in the flowchart of , analysis of the number of sensed A4 events during the time period in which the VCL is determined can be used to adjust the VCL-based AF evidence score, the AF threshold applied to the AF evidence score, or both. When the VCL is irregular due to a reduced AF threshold and / or little or no adjustment to the VCL-based AF evidence score, a low incidence or absence of sensed A4 events or multiple A4 sensing threshold crossings per VCL can increase the likelihood of detecting atrial tachycardia. The incidence of one sensed A4 event per VCL is relatively high due to unadjusted or increased AF thresholds and / or reduced AF evidence scores after adjustment for evidence of atrial events, thereby reducing the likelihood of detecting AF.

[0120] Fig.10700 is a flow chart of a method for detecting AF using motion sensor signals and VCL according to another example. After determining the VCL-based AF evidence score at box 702, the control circuit 206 can determine atrial event evidence from the motion signal at box 704, for example by counting sensed A4 events as described above. In this example, a shortening of the A1-A2 interval can be determined from the motion sensor signal as positive evidence of AF. At box 706, the A1 event and the A2 event are detected from the motion signal by the control circuit 206. The A1 event can be based on the ventricular electrical events after the identified ventricular electrical events, for example, Figure 7 The A1 event and the A2 event are sensed by the threshold crossing of the motion signal during the A1 window and the A2 window (which can be a heart rate adaptive window) shown. The control circuit 206 can determine the time interval between the sensed A1 event and the A2 event. The A1-A2 interval can be determined during each VCL in multiple VCLs during a predetermined time segment. In other instances, the A1-A2 interval can be determined at the beginning, end or during the selected VCL based on the sampling rate during the AF evidence scoring time segment of the VCL. Multiple A1-A2 intervals determined during different VCLs can be averaged to determine a representative A1-A2 interval during the time segment. In some instances, the A1-A2 interval is determined during a VCL during which an A4 event is not sensed or during a VCL immediately following a VCL during which an A4 event is not sensed.

[0121] At box 708, the shortening of the A1-A2 interval can be a positive indicator of AF and can be used to adjust the AF threshold. For example, the AF threshold compared to the AF evidence score can be lowered in response to detecting the shortening of A1-A2 to increase the likelihood of detecting AF during the period of irregular VCL. The control circuit 206 can detect the shortening of the A1-A2 interval by, for example, comparing the A1-A2 interval determined during the period of collecting VCL with the previously determined A1-A2 interval during the time period with low VCL irregularity (or low AF evidence score). The time period of low VCL irregularity can be identified as the time period in which the number of occupied bars in the Lorentz plot histogram is less than a predetermined threshold. During normal sinus rhythm, the number of points (ΔVCL1, ΔVCL2) in the histogram bars around the origin of the Lorentz plot is high, so that the number of occupied bars outside the origin segment minus the number of points (ΔVCL1, ΔVCL2) within the origin segment is a low value, for example, zero or even negative. Thus, a period of low VCL irregularity can be identified when the AF evidence score is zero or less. A normal or baseline A1-A2 interval can be determined during this period of low VCL irregularity for comparison with the A1-A2 interval during the unknown rhythm. Any period of time with a low number of bars occupied outside the original segment, a high number of (ΔVCL1, ΔVCL2) points in the original segment, or a generally low unadjusted AF evidence score can be identified as a period of lower VCL variability during which a normal or baseline A1-A2 interval can be determined.

[0122] In response to a threshold reduction in the A1-A2 interval compared to a previously determined A1-A2 interval, an A1-A2 shortening may be detected at box 706. For example, if the A1-A2 interval determined at box 706 is at least 20% shorter than the A1-A2 interval determined during a low VCL irregularity period (e.g., during a known non-tachyarrhythmic rhythm), a shortening of the A1-A2 interval may be detected. In other instances, the A1-A2 interval determined at box 706 may be compared to a threshold A1-A2 interval stored in memory 210. In response to detecting a shortening of the A1-A2 interval (the "yes" branch of box 706), the AF threshold is adjusted at box 708. The AF threshold may be lowered to increase the likelihood of detecting AF based on the AF evidence score determined from the VCL. The AF threshold may be reduced by a predetermined decrement or percentage, for example, 20%, 30%, or other value.

[0123] When no shortening of the A1-A2 interval is detected, the process may proceed from block 706 to block 710 without adjusting the AF threshold. Fig. 9As described, the AF threshold may be adjusted at block 708 based on evidence of atrial events determined at block 704, even if no A1-A2 interval shortening is detected. Thus, the AF threshold may be lowered at block 708 based on the absence (or very low count) of sensed A4 events during the time period and / or based on the detection of A1-A2 interval shortening. In various examples, the AF threshold may be lowered in response to the absence of A4 sensed events or A1-A2 interval shortening; lowered only when both A1-A2 interval shortening and no A4 events are detected; or lowered by a first adjustment based on the absence or low incidence of detected A4 events once per VCL, and lowered by a second adjustment in response to A1-A2 interval shortening.

[0124] After the AF threshold is adjusted as needed at box 708, in addition to or as an alternative to adjusting the AF threshold, the AF evidence score can be adjusted based on the detection of shortening of the A1-A2 interval. For example, the AF evidence score can be increased in response to detecting a shortening of the A1-A2 interval. The increase can be a predetermined increment or percentage of the AF evidence score, thereby making it more likely that AF will be detected during the time period of VCL irregularity. As described above, the AF evidence score can be additionally or alternatively adjusted based on atrial event evidence.

[0125] At box 712, the AF evidence score is compared to the AF threshold after adjusting one or both as needed based on atrial event evidence and / or A1-A2 interval shortening detection. If the AF evidence score is greater than the AF threshold, then at box 714, the rhythm during the AF evidence score time period (during which the VCL was acquired) is classified as AF. If not, then at box 716, the rhythm is not classified as AF. The process can return to box 702 to determine the next AF evidence score in the next time period.

[0126] Fig.11 8 is a graph of an example accelerometer signal 802, an ECG signal 804 with event markers, and a ventricular EGM signal 806 during a non-atrial tracking pacing mode with normal AV intact conduction. The accelerometer signal 802 is obtained by the control circuit 206 from the motion sensor 212 ( Figure 3 An example of a motion signal received by an accelerometer 802 is shown in FIG. Fig.11 802 is shown as an unrectified signal, but may be rectified by the motion sensor 212 or the control circuit 206 for sensing an A4 event. Along the motion signal 802, an A1 event, an A2 event, an A3 event, and an A4 event are represented.

[0127] The "VE" marker shown along the ECG signal 804 indicates the end of the A3 window, e.g., corresponding to Figure 7802 crosses the A4 sensing threshold. The "VS" mark indicates an R-wave sensed event. The R-wave (labeled "R") of the EGM signal 806 is sensed by the sensing circuit 204, which transmits the R-wave sensed event signal to the control circuit 206. In this example, one A4 signal is sensed per VCL (per RR interval). The presence of one A4 signal sensed per VCL is evidence of a counteracting atrial tachyarrhythmia. In this example, the VCL (determined as the RR interval) is not irregular, so the AF evidence score will be very low or even negative.

[0128] Fig.12 824, and ventricular EGM signal 826 during atrial fibrillation. No clear A4 signal is observed on the accelerometer signal 822. After each end time (VE) of the A3 window, there is no AS marker indicating that no A4 event was detected. The VS marker indicates the time of the R-wave sensed event, which corresponds to the R-wave of the EGM signal 826. It is observed that the RR intervals 830 in this example are irregular. This irregularity may result in a relatively high AF evidence score. The absence of A4 events may result in an atrial event evidence score of zero, so there is no need to adjust the AF evidence score (or AF threshold). Based on the VCL irregularity and the absence of any A4 events sensed from the motion signal, it is likely that AF can be correctly detected.

[0129] Various examples of medical devices and methods for detecting atrial tachyarrhythmias using intraventricular motion signals have been described. It should be understood that, depending on the example, certain actions or events of any method described herein may be performed in a different order, may be added, merged, or excluded entirely (e.g., not all described actions and events are necessary for the method technique). In addition, in some instances, actions or events may be performed simultaneously rather than sequentially, for example, by multithreading, interrupt processing, or multiple processors. In addition, for purposes of clarity, although certain aspects of the present disclosure are described as being performed by a single circuit or unit, it should be understood that the techniques of the present disclosure may be performed by a combination of units or circuits associated with, for example, a medical device.

[0130] The following describes example techniques according to the present disclosure.

[0131] Example 1: A method comprising: determining a first atrial arrhythmia score from a ventricular event sensed by a sensing circuit of an implantable medical device, the first atrial arrhythmia score being associated with the presence of an atrial arrhythmia; determining a second atrial arrhythmia score from an intraventricular signal generated by a sensor of the implantable medical device, the intraventricular signal comprising an atrial mechanical event signal accompanying an atrial contraction period, the second atrial arrhythmia score being based on the atrial mechanical event signal; detecting an atrial arrhythmia based on the first atrial arrhythmia score and the second atrial arrhythmia score; and updating atrial arrhythmia episode event data stored in a memory of the implantable medical device in response to detecting the atrial arrhythmia, the update comprising an indication of the detected atrial arrhythmia.

[0132] Example 2: A method according to Example 1, wherein detecting the atrial arrhythmia includes: adjusting the first atrial arrhythmia score based on the second atrial arrhythmia score; comparing the adjusted atrial arrhythmia score with an arrhythmia threshold; and detecting the atrial arrhythmia in response to the adjusted first atrial arrhythmia score being greater than the arrhythmia threshold.

[0133] Example 3: The method of example 2, wherein the control circuit is further configured to adjust the arrhythmia threshold in response to the second atrial arrhythmia score being less than an adjustment threshold.

[0134] Example 4: The method according to Example 2 further includes: detecting multiple atrial mechanical events from the intraventricular signal during an atrial event window; and adjusting at least one of the first atrial arrhythmia score and the arrhythmia threshold in response to detecting the multiple atrial mechanical events during the atrial event window.

[0135] Example 5: The method of any one of Examples 1 to 4, further comprising: detecting a plurality of atrial mechanical events from the intraventricular signal during an atrial event window; and detecting atrial flutter in response to detecting the plurality of atrial mechanical events.

[0136] Example 6: A method according to any one of Examples 1 to 5, wherein detecting the atrial arrhythmia includes: comparing the first atrial arrhythmia score with a first threshold; comparing the second atrial arrhythmia score with a second threshold; and detecting the atrial arrhythmia in response to the first atrial arrhythmia score being greater than the first threshold and the second atrial arrhythmia score being less than the second threshold.

[0137] Example 7: The method of any one of Examples 1 to 6, wherein determining the second atrial arrhythmia score comprises sensing the atrial mechanical event signal from an intraventricular motion signal generated by a motion sensor of the sensor.

[0138] Example 8: The method of any one of Examples 1 to 7, wherein determining the second atrial arrhythmia score comprises sensing an atrial mechanical event from one of an intraventricular impedance signal generated by the sensor and a intraventricular pressure signal generated by the sensor.

[0139] Example 9: A method according to any one of Examples 1 to 8, wherein determining the second atrial arrhythmia score includes: identifying multiple ventricular events; initiating an atrial event window after each of the ventricular events; determining a count of atrial mechanical event signals sensed from the intraventricular signals during the atrial event window; and determining the second atrial arrhythmia score based on the count of sensed atrial mechanical event signals.

[0140] Example 10: The method according to Example 9 further includes: determining an atrial event window duration from the start of the atrial event window until the next ventricular event among the multiple ventricular events; and in response to the atrial event window duration being less than a threshold window duration, ignoring the atrial event window when determining the second atrial arrhythmia score.

[0141] Example 11: The method according to Example 9 further includes: sensing R waves from the cardiac electrical signals received by the sensing circuit; identifying the multiple ventricular events including the R waves sensed by the sensing circuit from the cardiac electrical signals; determining the first atrial arrhythmia score by determining multiple ventricular cycle lengths between consecutive pairs of the multiple ventricular events; and determining the second atrial arrhythmia score from the intraventricular signal during a time segment including the multiple ventricular cycle lengths.

[0142] Example 12: A method according to any one of Examples 1 to 11, further comprising: identifying multiple ventricular events, the multiple ventricular events including ventricular pacing pulses delivered by a pulse generator of the implantable medical device; determining a percentage of the multiple ventricular events that are ventricular pacing pulses; and rejecting the atrial arrhythmia detection in response to the percentage being greater than a threshold percentage.

[0143] Example 13: A method according to any one of Examples 1 to 12, wherein determining the second atrial arrhythmia score from the intraventricular signal includes: sensing a systolic ventricular event signal from the intraventricular signal; sensing a diastolic ventricular event signal from the intraventricular signal; determining a ventricular contraction time interval extending from the systolic ventricular event signal to the diastolic ventricular event signal; comparing the ventricular contraction time interval with a shortening threshold; detecting ventricular contraction shortening based on the comparison of the ventricular contraction time interval with the shortening threshold; and increasing the second atrial arrhythmia score in response to detecting the ventricular contraction shortening.

[0144] Example 14: A method according to any one of Examples 1 to 13, further comprising: detecting a shortening of the ventricular contraction time interval from the intraventricular signal; adjusting an arrhythmia threshold in response to detecting the shortening; adjusting the first atrial arrhythmia score based on the second atrial arrhythmia score; and detecting the atrial arrhythmia in response to the adjusted first atrial arrhythmia score being greater than the adjusted arrhythmia threshold.

[0145] Example 15: A method according to any one of Examples 1 to 14, further comprising: determining the first atrial arrhythmia score by identifying multiple ventricular events including ventricular pacing pulses delivered by a pulse generator of the implantable medical device and determining a ventricular cycle length difference from the multiple ventricular events; determining the second atrial arrhythmia score by determining a count of ventricular cycles of the multiple ventricular events during which a single atrial mechanical event signal is sensed from the intraventricular signal; determining a percentage of the multiple ventricular events identified as ventricular pacing pulses; reducing an atrial arrhythmia detection threshold in response to the second atrial arrhythmia score being less than an atrial event threshold and the percentage of the multiple ventricular events identified as ventricular pacing pulses being greater than a pacing frequency threshold; and detecting the atrial arrhythmia in response to the first atrial arrhythmia score being greater than the reduced atrial arrhythmia detection threshold.

[0146] Example 16: A method according to any one of Examples 1 to 15, further comprising: generating ventricular pacing pulses by a pulse generator of the implantable medical device according to a first pacing mode; and switching to generating ventricular pacing pulses by the pulse generator according to a second pacing mode different from the first pacing mode in response to detecting the atrial arrhythmia.

[0147] Example 17: The method of any one of Examples 1 to 16, further comprising: in response to detecting the atrial arrhythmia, controlling a pulse generator of the implantable medical device to withhold anti-tachycardia pacing therapy.

[0148] Example 18: The method of any one of Examples 1 to 17, further comprising transmitting the atrial arrhythmia episode event data via a telemetry circuit of the implantable medical device.

[0149] Example 19: A non-transitory computer-readable storage medium comprising a set of instructions that, when executed by a control circuit of an implantable medical device, cause the device to: determine a first atrial arrhythmia score from a ventricular event sensed by a sensing circuit of the implantable medical device, the first atrial arrhythmia score being associated with the presence of an atrial arrhythmia; determine a second atrial arrhythmia score from an intraventricular signal generated by a sensor of the implantable medical device, the intraventricular signal comprising an atrial mechanical event signal accompanying an atrial contraction period, the second atrial arrhythmia score being based on the atrial mechanical event signal; detect an atrial arrhythmia based on the first atrial arrhythmia score and the second atrial arrhythmia score; and update atrial arrhythmia episode event data stored in a memory of the implantable medical device in response to detecting the atrial arrhythmia, the update comprising an indication of the detected atrial arrhythmia.

[0150] In one or more instances, the functions described may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored in the form of one or more instructions or codes on a computer-readable medium and may be performed by a hardware-based processing unit. A computer-readable medium may include a computer-readable storage medium, which corresponds to a tangible medium, such as a data storage medium (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store the desired program code in the form of instructions or data structures and can be accessed by a computer).

[0151] Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuit systems. Thus, the term "processor" as used herein may refer to any of the foregoing structures or any other structure suitable for implementation of the techniques described herein. Furthermore, the techniques may be fully implemented in one or more circuits or logic elements.

[0152] Therefore, in the above description, medical devices have been presented with reference to specific examples. It should be understood that the various aspects disclosed herein can be combined in different combinations other than the specific combinations presented in the drawings. It should be understood that various modifications can be made to the reference examples without departing from the scope of the present disclosure and the appended claims.

Claims

1. A medical device comprising: a memory configured to store a first atrial contraction event threshold and a second atrial contraction event threshold; a sensor configured to sense a cardiac mechanical signal; a pulse generator configured to deliver ventricular pacing pulses; as well as A control circuit configured to: During a time interval that includes multiple ventricular cycles: applying the first atrial contraction event threshold to the cardiac mechanical signal during a first window of the plurality of ventricular cycles; applying the second atrial contraction event threshold to the cardiac mechanical signal during second windows of the plurality of ventricular cycles, each of the second windows starting from an end time of one of the first windows, the second atrial contraction event threshold being less than the first atrial contraction event threshold; and accumulating atrial event evidence from said cardiac mechanical signals sensed during said second window; determining, based at least on the accumulated atrial event evidence, that atrial arrhythmia criteria are met for the time interval; responsive to the atrial arrhythmia criteria being met for the time interval, generating an output; and The memory is further configured to store the output.

2. The medical device according to claim 1, characterized in that The control circuit is further configured to generate the output as a rhythm classification by classifying the time interval as at least one of an atrial arrhythmia or a non-atrial arrhythmia based at least on the accumulated atrial event evidence.

3. The medical device according to claim 2, characterized in that The control circuit is further configured to: accumulating atrial event evidence from said cardiac mechanical signals sensed during said second window during a plurality of time intervals; classifying each of the plurality of time intervals based at least on the accumulated atrial event evidence; determining a threshold number of time intervals to be classified as an atrial arrhythmia; and An atrial arrhythmia episode is detected in response to the threshold number of time intervals being classified as an atrial arrhythmia.

4. The medical device according to any one of claims 1 to 3, characterized in that: The control circuit is further configured to: For each of the second windows: determining a duration of the second window; determining whether the duration satisfies a threshold duration; and The atrial event evidence is accumulated from the cardiac mechanical signals sensed only during the second window having a duration satisfying the threshold duration.

5. The medical device according to any one of claims 1 to 3, characterized in that: The control circuit is further configured to: determining whether the motion signal crosses the first atrial contraction event threshold during a ventricular cycle in the plurality of ventricular cycles; and In response to the motion signal crossing the first atrial contraction event threshold during the ventricular cycle, awaiting a next ventricular cycle of the plurality of ventricular cycles without accumulating atrial event evidence from the motion signal sensed during the ventricular cycle.

6. The medical device according to any one of claims 1 to 3, characterized in that: The control circuit is further configured to: identifying a plurality of ventricular events in the plurality of ventricular cycles of the first time interval, the plurality of ventricular events comprising ventricular pacing pulses delivered by the pulse generator; and Each of the first windows is initiated at a start time after a corresponding one of the plurality of ventricular events.

7. The medical device according to any one of claims 1 to 3, characterized in that: The control circuit is further configured to accumulate the atrial event evidence by determining one or more signal features from the motion signal sensed during the second window.

8. The medical device according to any one of claims 1 to 3, characterized in that: The control circuit is further configured to: generate the output by storing at least a segment of the cardiac mechanical signal sensed by the sensor in the memory; The medical device further includes telemetry circuitry configured to transmit the output.

9. The medical device according to any one of claims 1 to 3, characterized in that: The control circuit is further configured to: detecting an atrial arrhythmia episode in response to at least the atrial arrhythmia criterion being satisfied for the time interval; and The output is generated by at least one of: determining an atrial arrhythmia burden using the time interval; and Adjusting pacing therapy delivered by the pulse generator.

10. The medical device according to any one of claims 1 to 3, characterized in that: The pulse generator is further configured to: generating ventricular pacing pulses in an atrial tracking ventricular pacing mode; and Responsive to the control circuit determining that the atrial arrhythmia detection criteria are met, switching to generating the ventricular pacing pulses in a non-atrial tracking ventricular pacing mode.

11. A non-transitory computer readable medium storing a set of instructions that, when executed by control circuitry of a medical device, cause the medical device to: Sensing cardiac mechanical signals; During a time interval that includes multiple ventricular cycles: applying a first atrial contraction event threshold to the cardiac mechanical signal during a first window of the plurality of ventricular cycles; applying a second atrial contraction event threshold to the cardiac mechanical signal during second windows of the plurality of ventricular cycles, each of the second windows starting from an end time of one of the first windows, the second atrial contraction event threshold being less than the first atrial contraction event threshold; and accumulating atrial event evidence from said cardiac mechanical signals sensed during said second window; determining, based at least on the accumulated atrial event evidence, that atrial arrhythmia criteria are met for the time interval; and In response to the atrial arrhythmia criteria being met for the time interval, an output is generated.